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A quantitative reporter system for the study of cytokine gene transcrip-
tion in primary human mesangial cells. E. Stylianou and L. Zhao, Division
of Renal and Inflammatoiy Disease, Department of Medicine, University,
Hospital, Nottingham, England, United Kingdom. Mesangial cell cytokine
production in the inflamed glomerulus is critical to amplification of the
inflammatory response. However, little is understood of how the prom-
flammatory cytokine interleukin I (IL-i) regulates the production of the
chemoattractant cytokine IL-8 and the immunoregulatory cytokine IL-6.
Previously, IL-Ia stimulation has been reported to activate the NFKB
family of transcription factors in cytosolic and nuclear extracts of human
mesangial cells (HMC). The aim of this study was to develop for the first
time a quantitative reporter assay to measure IL-i regulated transcription
factor activity in primary HMC to which regions of the IL-8 and IL-6
promoter had been transferred. Liposome mediated transfer of luciferase
reporter Constructs containing the CDNA of the tL-6 (gift of S. Akira) or
IL-8 (gift of K. Matsushima, Japan) promoters regions were employed
each of which included the regulatory sites of both the NFKB and NF-IL-6
families of transcription factors. Fifty percent confluent cell cultures were
transfected for 24 hours and then stimulated with tL-la (20 ng/ml). Cells
were then gently washed, lysed and luciferase activity quantitated in a
Turner luminometer. An increase in luciferase expression provided a
measure of increased transcription factor activity. The quantities of DNA
and liposomes were optimized and liposome mediated transfer was
compared to the DEAE Dextran method employed, classically, for gene
transfer into transformed cell lines. IL-i induced IL-6 and IL-8 promoter
activity in a dose dependent manner and up-regulated the expression of
both promoters by approximately threefold over 24 hours. Disruption of
the NFKB and NF-IL-6 sites or cotransfer of cytokine promoter with the
cDNA of the NFKB inhibitor IKBa abrograted cytokine promoter and
hence luciferase reporter activity. The defined luciferase reporter system
will facilitate study of the signaling pathway that links these transcription
factors with IL-I at the plasma membrane. These studies indicate that tL-1
can drive the transcription of HMC IL-fl and IL-8 genes and that the
NFKB and NF-IL-6 proteins are important regulators of this process.
Steroids increase non-phlogistic uptake of apoptotic cells by glomeru-
lar phagocytes. J. Hughes, Y Liu, J. Van Damme, and .1. Savill, Division of
Renal and Inflammatory Disease, Department of Medicine, University Hos-
pital, Nottingham, England, United Kingdom, and Rega Institute, Katholieke
Universiteit Leuven, Leuven, Belgium. Ncutrophils (PMNs) may undergo
apoptosis within inflamed glomeruli leading to phagocytosis by glomerular
macrophages (Mø) and mcsangial cells. Human monocyte-derived Mø-
secreted thrombospondin (TSP) binds the apoptotic PMN to Mø surface
vitroneetin receptor (VnR) and CD36. We have recently shown that
cultured human mesangial cells (HMC) ingest apoptotic PMNs by a
CD3fi-independent TSP/VnR recognition mechanism). This study exam-
ines (1) the release of the pro-inflammatory chemokines interlcukin 8
(TL-8) and monocyte chemotactic protein-l (MCP-1) by human monocyte-
derived Mø and HMC following ingestion of apoptotie human PMNs, and
(2) the effects of steroids upon Mø and HMC ingestion of apoptotic
PMNs. Mø and HMC were interacted with either aged apoptotic PMNs,
opsonized zymosan (Mø only), 10 ng/ml IL-I (FIMC only) or medium
alone in 24 well plates for I or 3 hours, respectively. After careful washing,
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300 p1 of medium was added to each well which was aspirated after 24
hours and assayed for IL-8 or MCP-1 by specific ELISA. Results (mean
SEM, N = 4) are shown below.
Interaction
(%PMN uptake) IL-8 ng/ml MCP-1 ng/ml
Mø alone 4.7 0.2 2.3 2.3
Mø/PMN (21%) 6.7 0.35 3.3 1.4
Mø/zymosan 585 75 13.6 2.4k'
HMC alone 3 0.6 11.9 3.2
HMC/PMN (14%) 1.4 0.2 8.7 0.3
HMC/IL-1 37 5 38 4'
ap <0.05
Preincuhation of Mø or HMC with 200 nat methyl prednisolone for 24
hours prior to interaction with apoptotic PMNs significantly increased
PMN uptake by 264 14% (mean SEM, N 10) or 216 19% (mean
SEM, N = 6), respectively, compared to control. Increased phagocytosis
was dose dependent and specific, being completely inhibited by the steroid
antagonist RU38486. Therefore, despite utilizing different recognition
mechanisms, MØ and HMC clearance of apoptotic PMNs is non-phlogis-
tic, thus emphasizing the injury-limiting nature of this mode of cell
removal. In addition, Mø and HMC ingestion of apoptotic PMNs is
significantly increased by preincubation with methyl prednisolone, a
common treatment for various types of inflammatory nephritis.
Use of biosensor technology in epitope mapping studies on human
myeloperoxidase. P. T Chapman, A.K Short, and G.M. Lockwood, Cam-
bridge University, Cambridge, and Department of Medicine and Renal Unit,
Manchester Royal Infirma,y, Manchester, England United Kingdom. Auto-
antibodies to myeloperoxidase (MPO) are associated with the potential to
develop creseentic nephritis, however, there is uncertainty about the
prognostic implications of such a finding because circulating anti-MPO
antibodies may be found in a variety of other conditions that may not all
carry a poor renal prognosis. For the nephrologist anti-MPO antibodies
may he found in three groups of patients with renal disease, most
commonly in the renal vasculitis of microscopic polyangiitis (Group A), in
conjunction with anti-GBM antibodies in up to 30% of patients with
anti-GBM nephritis (Group B), and rarely as the sole circulating autoan-
tihody in patients with the renal involvement of Wegener's granulomatosis
(Group C). We used Bioscnsor technology to determine whether differ-
ences exist in the epitope specificity of anti-MPO antibodies found in
groups A, B and C. Purified human MPO was captured onto the biosensor
chip using a polyclonal rabbit anti-human MPO antibody, samples of sera
were then consecutively injected onto the surface of the elup until no
increase in material binding was seen, and at this point the next serum
sample was injected as before. Additional binding by the second sample to
the MPO was indicative of recognition of a different epitope, while
inhibition of binding by the previous sera indicated that the subsequent
samples were recognizing the same epitope. By using hiosensor technology
to study biomoleeular interactions in real time we have shown that the
autoimmune response in patients in group A (N = 15) is indeed restricted
to a single epitope that constitutes an immuno-dominant region on the
surface of the molecule. The sera from patients in group B (N = 6) were
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consistently found to recognize different epitopes to those in group A.
Repetitive studies suggested they recognized more than one epitope.
Inhibition of binding to the captured MPO was seen only after 4 of the 6
samples had bound consecutively to the antigen. Likewis, anti-MPO
antibodies from patients in group C (N = 4) also recognized different
epitopes from those in group A. All sera screened in the biosensor were
also screened in an ammonium thiocyanate disruption ELISA to measure
their relative affinity to MPO and to confirm that any additional binding in
the biosensor was due to recognition of a different epitope and not the
result of significant differences in affinity. We have shown that patients
with anti-MPO positive systemic vasculitis recognize a single epitope on
human MPO, indicating an immuno-dominant region on the molecule
that is clearly different from the epitopes recognized by anti-MPO positive
sera from patients with anti-GBM nephritis or Wegener's granulomatosis,
and the prognostic implications of these findings will be discussed.
Effect of fusion protein CTLA4-lg on the development of experimental
autoimmune glomerulonepritis (EAG) in the WKY rat. J. Reynolds, J.
Cross, A.M. Karkar, J. Smith, V.0. Newman, and C.D. Pusey. Renal Unit,
Department of Medicine, Royal Postgraduate Medical Schoo4 London,
England, United Kingdom. In our model of experimental autoimmune
glomerulonephritis (EAG), WKY rats immunized with collagenase-solu-
hilized rat GBM in FCA develop circulating and deposited anti-GBM
antibodies, accompanied by albuminuria, deposits of fibrin in the glomer-
uli, and focal necrotizing glomerulonephritis with crescent formation. This
model of EAG is also characterized by glomerular infiltration with T cells
that precedes an influx of macrophages, and can be ameliorated by anti-T
cell monoclonal antibody therapy. We examined the effect of administra-
tion of the murine fusion protein CTLA4-1 g, which inhibits the activation
of T cells by blocking the co-stimulatory signal between CD28/CTLA4 and
B7, on the development of EAG. Different doses of CTLA4-lg were given
throughout the disease, or only at the time of immunization. Continued
treatment with CTLA4-lg 1 mg iv. at the time of immunisation and then
0.1 mg i.p. 3 times per week for four weeks, resulted in a marked reduction
in anti-GBM antibody production, albuminuria, deposits of fibrin in the
glomeruli, severity of glomerular abnormalities, and infiltrating T cells and
macrophages. When CTLA4-lg was given as a single iv. dose at the time
of immunization, a dose dependent effect was observed over four weeks.
A dose of 0.5 mg had no effect, I mg produced a moderate reduction in
nephritis, and 2 mg had a more marked therapeutic effect. The table shows
mean results for different groups of rats (N = 4).
Abnormal
glomeruli %Albuminuria __________ ___________
_________
mg/day Total Severe T cells Macrophages
EAG 553 100 70 64 124
Normal 0 0 0 28 0
CTLA4-lg 269 55 20 35 91
(continued)
CTLA4-lg 290 70 30 44 108
(2 mg stat)
_______ __________ ____________________
These results demonstrate that blockade of B7 with fusion protein
CTLA4-lg reduces the severity of crescentic nephritis in EAG. This
suggests that strategies targeting T cell co-stimulation may provide a novel
approach in the treatment of Goodpasture's disease.
Acute starvation response to metabolic acidosis in L6 skeletal muscle
cells. A. llevington, C. Poulter, J. Brown, and J. Walls, Department of
Nephrology, Leicester General Hospital, Leicester, Leice.ster, England, United
Kingdom. ljremic metabolic acidosis (MA) stimulates protein degradation
(PD) leading to muscle wasting. Previous work has shown that, in cultured
Lb skeletal muscle cells, stimulation of PD and leucine (Leu) oxidation by
acid may be caused by impaired glycolysis, suggesting that acid induces a
starvation response whereby amino acids are harvested from protein as
fuels substituting for glucose. Impaired protein synthesis (PS) occurs in
muscle in acute starvation. The aim of the present study was to determine
whether acid (like acute starvation) can also inhibit PS, and whether
compensatory increases in consumption of fuels other than Leu could also
he detected. PS('4C-phenylalaninc incorporation) was measured in L6
cells in NEM+2% serum at acid pH (7.1) or control pH (7.5). After 24
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hours, acid inhibited PS (7.7 0.2 nmol Phe/4 hr/35 mm culture well vs.
8.9 0.1 in controls, P = 0.003) and this was maintained at 72 hours. In
vitro this could arise because acid only inhibits the rapid PS occurring in
dividing cells. However, when division was abolished with IO M eytosine
arabinoside, PS inhibition by acid still occurred (6.9 0.1 vs. 8.3 0.2 at
control pH, P < 0.05). Elevated PD and impaired PS together led to loss
of 7% of the total protein in only 28 hours (—21 3 .rg/well, P = 0.004).
Acid also stimulated consumption of exogenous fuels: pyruvate (Pyr)
(7.4 0.2 nmol/j.sg protein/24 hr vs. 5.1 0.3 in controls, P < 0.05) and
glutamine (GIn) (5.3 0.1 mnol/ptg protein/24 hr vs. 4.3 0.2 in controls,
P < 0.02). This combination of impaired glycolysis and PS with increased
PD and increased Leu, Pyr and GIn consumption is consistent with an
acute starvation response to acid, and provides further evidence that
defective use of metabolic fuels contributes to muscle wasting in uremic
metabolic acidosis.
Revisiting the evidence-base of dialysis practice: The role of Cochrane
Systematic Reviews. C. Daly, M. Campbell, J. Cody, C. Donaldson, A.
Grant, I. Khan, P. Lawrence, L. Vale, S. Wallace, and A. MacLeod,
Department of Medicine and Therapeutics, Health Services Research Unit
and Health Economic Research Unit, University of Aberdeen, Aberdeen,
Scotland, United Kingdom. The Renal Association's Standards Document
aims to improve patient outcome by encouraging the implementation of
best clinical practice. Cochrane Systematic Literature Reviews can identify
best practice using a robust methodology including a literature search,
assessment of study quality, data extraction and qualitative and quantita-
tive data syntheses. We are reviewing six key clinical decision-making
areas in chronic dialysis with significant resource implications. The first
comparing bicarbonate with acetate hemodialysis is illustrative. A total of
11876 abstracts of possible RCTs relevant to ESRD management were
identified, of which 18 studies fulfilled our strict methodological criteria
for inclusion in our first review.
Table 1. Meta-analysis showing reduction in symptoms during
hemodialysis with bicarbonate dialysis
Adverse symptom
during HD
No. of
treatmentsa
Odds ratio
(95% CI.) NNTh
Headaches 1563 0.84 (0.71 to 0.99) 33
Nausea/vomiting 1563 0.42 (0.26 to 0.66) 49
Muscle cramps 1452 0.97 (0.77 to 1.22) 290
Symptomatic hypotension 198 0.28 (0.11 to 0.69) 17
Non-specific intolerance 1542 0.79 (0.67 to 0.93) 22
a Total number of hemodialysis treatments studied for each symptom
' NNT, the number needed to treat, is the average number of hemodi-
alysis treatments with bicarbonate needed to produce one additional
treatment without that specific symptom
The results of this meta-analysis show only a modest benefit of bicarbon-
ate. This, given the increased cost of bicarbonate dialysis, might have
influenced its widespread introduction into general clinical practice.
Systematic literature reviews have a significant role to play in the thorough
evaluation of new health technologies.
Staphylococci direct leukocyte recruitment across mesothelium via
interleukin-8 dependent and independent mechanisms. H. Fear, J.D.
Williams, and N. Topley, Institute of Nephrology, University of Wales College
of Medicine, Royal Infirmary, Cardiff Wales, United Kingdom. Recent in
vitro and in viva data suggest that the synthesis of C-X-C and C-C
chemokines by the mesothelial cells play an important role in generating
the chemotactic gradient necessary to attract leukocytes into the perito-
neum during infection. We know little, however, about how these pro-
cesses are initiated and what role the infecting organism might play in the
process. In the present study we have identified two potential mechanisms
by which Staphylococcal .rpp. might influence PMN migration across
mesothelium (i) by intrinsic bacterial chemoattractant activity, and (ii) via
activation of human peritoneal mesothelial cells (HPMC) and subsequent
synthesis of chemokines. Cell free supernatants (CFS) derived from S.
aureus or S. epidermidis contained significant chemoattractant activity as
assessed by the migration of PMN across collagen-coated porous mem-
branes (0.3 p. pores). Undiluted CFS increased PMN migration by
between 29% and 80% above control (13,050 PMN/60 mm) depending on
Immunohistory
cells/50 glomeruli
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species. Stimulation of HPMC monolayers with S. aureus or S. epidermidis
CFS resulted in a time- and dose-dependent generation of IL-8. After 24
hours the IL-8 levels induced by neat CFS (expressed as pg/pg cell
protein) were 0.39 0.13, 7.28 2.31 and 13.40 2.05 for control, S.
aureus and S. epider,nidis CFS, respectively (N = 7,P = 0.0277 vs. control).
This induction of IL-8 synthesis was preceded by the time dependent
induction of IL-8 mRNA as assessed by RT/PCR. Using our tissue culture
insert system, where an HPMC monolayer is established on one side of a
porous membrane, we were able to demonstrate that Staphylococcal CFS
was capable of initiating PMN transmigration across the HPMC mono-
layers. Following one hour stimulation the number of PMN crossing the
monolayer increased from 0.4 0.2 (X 10) in controls to 14.0 6 and
37.0 10 for S. aureus and S. epidermidis CFS, respectively (N = 3, P =
0.0277 vs. control). This increased transmigration was independent of
HPMC IL-8 secretion as demonstrated by the lack of effect of blocking
polyclonal IL-8 antibody. Following extended stimulation (24 hr) the
number of PMN crossing the HPMC monolayer increased from 9.0 4.0
(X 10) in control to 102 13 and 506 33 for S. aureus and S.
epidermidis CFS, respectively (N = 3,P 0.0277 vs. control). Polyclonal
IL-8 antibody significantly reduced this PMN transmigration (40%)
following 24 hours of stimulation. These data suggest two mechanisms of
activation of neutrophil passage across mesothelium one independent of
IL-8 and related to direct bacterial chenioattractant activity, the other
dependent on the formation of an IL-8 chemotactic gradient.
First data analysis from the UK Renal Registry pilot scheme. A
preliminary analysis of performance of renal units compared with the
Renal Association standards. D. Ansell, T. Feest, and P. Roderick, on behalf
of the Renal Registiy subcommittee of the Renal Association. The pilot
project of the UK Renal Registry has established computerized links with
6 renal units. We present here a comparative analysis of a subset of the
data for end-stage renal failure at 31.3.96. Included are: modality of
therapy; hemoglobin; serum calcium, bicarbonate, phosphate, albumin;
systolic and diastolic BPs. Performance is compared with the Renal
Association standards. As data were not normally distributed non-para-
metric statistics were used. The main analysis is of 3,800 patients from 4
units. Men outnumbered women by 6:4. Modality of therapy varied
significantly between units. Men aged 25 to 54 were significantly more
likely to receive home hemodialysis than women. Figures are percentages
of total stock.
Unit Transplants
Unit
HD
Home
HD
Disconnect
PD
Other
PD
A 50.9 25.6 8.5 3.8 11.2
B 41.5 23.3 3.1 29.5 2.6
C 44.3 29.6 3.9 18.1 1.1
D 58.6 30.6 2.1 8.2 0.5
All 49.1 27.3 5.0 14.4 4.2
For all the variables measured all units failed to approach the Renal
Association recommended standards. There was wide significant variation
between units, and for hemodialysis compared with CAPD. Major varia-
tions are illustrated in the following table:
Unit
% H
10
HD
b <
g/dl
PD
% Bicarh <
20 mmol/liter
HD PD
% AIb
35 g/
HD
umin <
liter
PD
A 51 29 65 12 19 49
B 44 24 32 2 20 42
C 57 41 11 4 13 51
D 59 45 53 2 16 44
Calcium and related data showed similar variations with between 13% and
26% of hemodialysis patients hypercalcemic in different units, and 10%
and 30% of CAPD patients. Between 79% and 52% of hemodialysis
patients had serum phosphates above the recommended standard in
different units, as did between 58% and 36% of CAPD patients. Analytical
routines are still being developed. These and additional comparative
analyses including sequential changes and patient outcomes will be
available to participating centers when they join the Renal Registry.
Reports will be produced every six months and center confidentiality will
be maintained. In conclusion, even with a small number of centers marked
differences in practice and standards emerge. Areas of good practice can
be identified and investigated to help raise standards in other centers. It is
clear that the Renal Association standards will be difficult to achieve. The
registry is becoming a powerful tool for audit, change, and research.
Cardiac hypertrophy and blood pressure—Relationship in early exper-
imental uremia. AC. McMahon, HA. Cramp, C.G.M. Millar, SE. Green-
wald, and S.M. Dodd, Anthony Raine Research Laboratories and William
Harvey Research Institute, St Bartholomew's Hospital and Department of
Morbid Anatomy, Royal London Hospital, London, England, United King-
dom. Hypertension is common in ESRD, and has been implicated in the
pathogenesis of LVH and cardiac dysfunction. The aim of this study was
to investigate the relationship between blood pressure (BP) and cardiac
hypertrophy in an animal model of mild to moderate uremia. Male Wistar
rats underwent 5/6 nephrectomy (U) or sham-operation (C). Four weeks
later mean arterial pressure (MAP, mm Hg) was measured directly
following cannulation of the left carotid artery. The hearts were then
removed and formalin fixed for measurements of left and right ventricular
lumen sizes (mm2), tissue areas (A, mm2) and left ventricular wall
thickness (mm). Body weights were not significantly different between the
groups. Plasma urea and creatinine were 2.5-fold greater in U than C
animals. BP and heart data are presented below:
Group MAP
LV
lumen
LV tiss
A
RV
lumen
RV tiss
A
LV
thick
C (N = 4) 136 12.706 46.080 5.630 13.086
-
2.334
5 1.922 2.211 0.819 1.087 0.099
U (N = 5) 111
6
12.204
1.015
56.120
3.152
6.706
0.693
13.360
1.163
2.692
0.090
% Duff 23% 1 4% 122% 119% 12% 115%
p < 0.03 NS 0.04 NS NSO.03
The data indicate that BP is not raised in mild/moderate uremia of short
duration, however, cardiac hypertrophy is still evident. We conclude that
uremia per se is a more immediate determinant of cardiac hypertrophy
than BP in this model.
Mechanisms involved in the development of left ventricular hypertro-
phy following renal transplantation. E. Galiatsou, S. T. W. Morris, R.S. C.
Rodger, H. Elliott, and A. G. Jardine, Department of Medicine & Therapeutics
and The Renal Unit, Western Infinnaiy, Glasgow, Scotland, United Kingdom.
The role of hypertension in the development of left ventricular hypertro-
phy (LVH) in renal transplant recipients is often questioned. We calcu-
lated the average clinic blood pressure (BP) for the preceding year and
performed echocardiography, 24-hour ambulatory blood pressure moni-
toring (ABPM) and standard 12-lead electrocardiographs (ECGS) in 26
renal transplant recipients to assess the association between blood pres-
sure and left ventricular mass index (LVMI). The patients were trans-
planted between 1986 and 1992 and were randomised prospectively to
treatment with either prednisolone and azathioprine (Aza, N = 13) or
prednisolone and cyclosporine (CsA; N 13). Age and time on renal
replacement therapy were comparable between the two groups. Although
clinic blood pressure did not differ (141/83.8 1.5 vs. 139.8 5.6/82.6
2.37 for CsA vs. Aza) patients in the CsA group had significantly higher
24-hour mean diastolic blood pressure (80.3 1.5 vs 72.9 2.1; P =
0.013) and 24-hour mean systolic blood pressure (129.2 2.5 vs. 118.2
3.5, 1' = 0.037). In addition, CsA patients had no nocturnal dip in BP.
LVMI was greater in CsA patients (145.5 14.0 vs. 113.5 8.6; P
0.072) and there was a relationship between DBP and LVMI (r 0.36,
P 0.096) and between SBP and LVMI (r 0.42, P 0.051).
Furthermore, we found a significant relationship between LVMI and QT
dispersion on ECO (r = 0.611, P 0.003), a marker of increased
susceptibility to ventricular arrythmias and sudden cardiac death. We
propose that LVMI is related to blood pressure post-transplantation, and
that cyclosporine therapy is associated with a higher BP and higher LVMI.
Clinic measurement of BP is inadequate, and the targets for BP should be
considerably lower than 140/90 mm Hg if we are to prevent the develop-
ment of or cause regression of LVH.
Increased peroxynitrite production in uremia: Possible mechanism for
accelerated atherosclerosis. R.C. Thuraisingham, HA. Cramp, A.C. Mc-
Mahon, M. Wilkes, C.A. Nott, S.M. Dodd, and MM. Yaqoob, Anthony Raine
Research Laboratories and Departments of Morbid Anatomy, Royal Hospi-
tals Trust, London and Anaesthetics, Queen Elizabeth Hospital, Birming-
ham, England, United Kingdom. Uremia increases the risk of premature
cardiovascular death. Peroxynitrite (ONOO), a product of nitric oxide
(NO) and superoxide (0,) has been implicated in nonuremic atheroscle-
rosis. 02 levels are elevated in uremia, and we and others have shown
indirect evidence of increased NO production. Therefore, we investigated
the potential role of ONOO in uremic vascular disease in 2 experimental
models. Human microvascular endothelial cells were cultured in either
10% uremic (U) or control (C) human plasma and [NO] (X iO pM/liter)
measured in the supernatants. Cells cultured in U had higher basal NO
production [U, 1.4 (1.3 to 1.7), C, 1.0 (0.9 to 1.3); P <0.005] although the
final [NO] following bradykinin stimulation was similar [U, 1.8 (1.6 to 2.3)
vs. C, 1.9 (1.8 to 2.7); P = NS]. No alteration in eNOS MRNA expression
or iNOS induction was detected by RTPCR. These data provide direct
evidence for increased basal eNOS activation in endothelial cells under
uremic conditions. Uremia was induced in WKY rats (U-WKY) using a
two-stage 5/6 nephrectomy model with sham operated controls (C-WKY).
After eight weeks, blood pressure was not different between the groups.
Thoraeic aortas were stained for nitrosotyrosine (N-Tyr) (ONOO reacts
with tyrosine to form N-Tyr) using a specific polyclonal antibody and
scored for staining intensity. All U-WKY stained positive, with N-Tyr
being present predominantly in the endothelium and intima and to a lesser
extent in the adventitia. N-Tyr was not present in CWKY aortas. These
data indicate increased NO release and ONOO formation in uremia.
Taken together, these findings explain the reduced NO bioactivity due to
consumption by 02 in chronic renal failure. The resulting ONOO could
explain accelerated atherosclerosis in uremia.
Paraoxonase activity in chronic renal failure. 0. Hasseiwander, D.
McMaster, D.G. Fogarly, A.P. Maxwelt, D.P. Nicholls, and 1.5. Young,
Department of Clinical Biochemistiy, Royal Group of Hospitals Tmst and
The Queen's University, and The Regional Nephrology Unit, Belftist City
Hospital, Belfast, Northern Ireland. Patients with chronic renal failure have
a substantially increased risk of atherosclerosis, to which lipoprotein
oxidation may contribute. Paraoxonase is an enzyme tightly associated
with an apoA-l and clusterin containing HDL subspecies. It exists in two
common variants according to the presence of glutamine or arginine at
position 192. The A isoform (glutamine) is associated with low paraoxo-
nase activity, whereas the B isoform (argininc) is associated with high
paraoxonase activity. Paraoxonase decreases the formation of lipid perox-
ides and inhibits LDL oxidation; it has therefore been suggested that
paraoxonase is involved in the anti-atherogenic properties of HDL. The
aim of this study was to assess whether paraoxonase activity or phenotype
is altered in patients with chronic renal failure undergoing dialysis
compared with healthy control subjects. Serum samples were collected
from 72 healthy subjects and 72 renal patients pre- and post-dialysis. HDL
cholesterol and total cholesterol were significantly lower in the patient
group (0.83 0.28 vs. 1.18 0.38 mmol/liter and 4.35 1.46 vs. 4.81
0.77 mmol/liter, respectively, both I' < 0.05), while LDT. cholesterol and
triglycerides were not different. Paraoxonase activity was measured spec-
trophotornetrieally using paraoxon and phenylacetate as substrates. Para-
oxonase activity was lower in renal failure patients regardless of the
substrate used: 112.84 58.35 versus 155.03 70.32 U/mI, P < 0.001 for
paraoxon at p1-I 10.5 and 50.57 t 14.58 versus 65.86 15.65 U/mI serum
P < 0.001 for phenylacetate at pH 8.0. Phenotype distribution and allele
frequency were similar in renal patients and controls. Decreased paraoxo-
nase activity and hence a reduction in the antioxidant capacity of MDL
may contribute to the accelerated development of atheroseelerosis in
chronic renal failure.
Low-sodium hemodialysis without fluid removal improves blood pres-
sure control in chronic dialysis patients. P. Donohoe, C. Farmer, I Dullyn,
iC. Kingswood, D. Golds,nith, and P. Sharpstone, Renal Unit, Royal Sussex
County Hospital, Brighton, England, United Kingdom. Hypertension (HT)
associated with hemodialysis (LID) is related in the most part to salt and
water overload. The effect of a two week period of low-sodium hemodi-
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alysis (LSH) on ambulatory BP profiles (ABPM) was examined in 10
non-diabetic chronic hemodialysis patients, mean age 62.8 years (range 22
to 83 years). Baseline ABPM was performed over a 48-hour interdialytie
period over a one week period of normal sodium HD (NSH); plasma and
dialysate biochemistry were also measured. All patients then underwent a
2-week period of LSH, following which A-BPM and biochemical measure-
ments were repeated. Target weight was kept constant. Transthoraeic
bioimpedance was performed during HD to measure systemic vascular
resistance index (SVRI), ejection fraction (EF) and cardiac output (CO)
noninvasively. Eehoeardiography was performed in all patients pre-NSH
to assess presence or absence of left ventricular hypertrophy (LVH). A
low sodium diet (60 mM/day) was enforced, and target weight kept
constant. Questionnaires were used to assess symptomatology during both
study phases. Mean dialysate Na during NSH was 137.4 mmol/liter and
during LSH was 133 mmol/liter (P 0.000006). Mean daytime BP fell
from 146/85 mm Hg to 133/81 mm Hg following LSH (P = 0.023 for SBP,
P = 0.1 for DBP). Mean night time BP fell from 137/80 to 128/74 (P
0.007 for SBP, P = 0.01 for DBP). One patient required a reduction in
antihypertensive medication. Intradialysis hypotension was no more fre-
quent or severe during LSH compared to NSH; no patient developed
hyponatremia. There was no change in urea reduction ratios with LSH.
Bioimpedanee data showed a fall in SVRI from 3452 to 2534 Fl Ohm/rn2(P = 0.0022) and an increase in cardiac index from 2.7 to 3.189
liter/min/m2 with LSH (P = 0.00003). Echoeardiography confirmed LVH
in all 10 patients. Two patients reported increased fatigue and anorexia
during LSH. Only 1 patient reported dialysis cramps. We conclude that
LSH is an effective and well-tolerated means of BP control in chronic HD
patients, and that the mechanism is a reduction in peripheral resistance. It
may become an important adjunct to antihypertensive therapy in these
patients in the future.
Safety of on-line hemodiafiltration. J.E. Tattersall, R.N. Greenwood, and
K. Farrington, Lister Hospital, Stevenage, United Kingdom. Amyloidosis due
to beta-2-mieroglobulin (2m) accumulation is likely after five years of
dialysis. Hemodiafiltration (HDF) improves the clearance of 132m up to
fourfold. Sterile replacement fluid can be produced inexpensively by
on-line filtration of dialysate. Since 1992, we have provided routine on-line
HDF treatments using modified Fresenius A2008D dialysis machines and,
more recently, purpose built equipment (4008E). An additional pump
causes filtration of 10 to 25 liters per treatment and drives an identical
volume of dialysate into the venous bubble-trap via two polysuiphone
filters in series. The dialysate filters are replaced every six months and are
disinfeeted by daily hot rinse and weekly hot citric acid. A daily pressure
holding test ensures filter integrity. During 1992 to 1996 we performed
33,802 HDFs and 63,513 standard high-flux haemodialyses (HD) in 320
patients. During this period, 518,736 liters of dialysate were infused. The
incidence of fever and intra-dialytie symptoms were similar in HD and
HDF. There were seven adverse reactions to HDF (0.02%), including two
G-ve septicaemias, traced to filter and disinfection failure. All patients
recovered fully and had been using modified HD machines, requiring
manual procedures. No such reactions have occurred using newer ma-
chines, employing automatic disinfection and testing. The additional costs
of the HDF infusion line (f32.00), filters (D00 for 156 treatments) and
quality control (2.00) arc balanced by a 10% increase in urea clearance
that allows a proportional reduction in dialysis time, saving at least £5.00
per treatment.
Gaining an improvement in dialysis catheter infection through the
process of clinical audit. D. de Takats, W. Wong, C. Weston, R.M. Higgins,
M. Bewick, and i.E. Scoble, The Renal Unit, Dulwich, King's Healthcare,
London, England, United Kingdom. Although planned access is the ideal,
about half the patients requiring hemodialysis do not have suitable access.
Urgent insertion of dialysis catheters has a number of complications,
infection being an important one. If infection rates could be reduced by
changes in clinical practice, this would be a significant achievement with
benefits for morbidity, mortality and cost. During an initial three months
observation period, acute insertions of hemodialysis catheters were re-
corded. At the cnd of the period, details of all relevant bacteriological
results were collected and the two data sets collated. The infection rate
was unacceptably high. Such practices as prolonged use of uneuffed lines,
serial uncuffed lines, and exchanging lines over a guidewire, among others,
were felt to be responsible. The following protocol was therefore insti-
tuted: (a) acute access by cuffed catheter where time allows; otherwise by
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VasCath® into an internal jugular or femoral vein; (b) no VasCath® to
stay in for longer than three days. (e) After three days a Vas-Cath® should
be replaced by a cuffed catheter. (d) No Vas-Cath® is to be exchanged
over a guidewire. Having established the protocol into practice, the audit
was repeated in the same three month period a year later with the
following results: A reduction in infection rate from 52 of 74 insertions
(0.703 per line) to just 8 of 64 insertions (0.125 per line). Although a
similar number of patients were taken on, 10 less lines were inserted in the
second period (14% reduction). We feel these improvements were
consequent upon adopting the protocol.
Angiotensin converting enzyme (ACE) inhibitors increase serum potas-
sium even in anuric hemodialysis patients. S.M. Chandna, T.M. Pickett, K
Farrington, Department of Renal Medicine, Lister Hospital, Stevenage,
England, United Kingdom. Hyperkalemia is a recognized complication of
ACE-inhibitors (ACE-I) but its importance in dialysis patients is not well
appreciated. Of the 219 hemodialysis (HD) and CAPD patients in our unit
at the time of this study, 104 were on ACE-I therapy. We compared serum
potassium (K) levels before and one month after starting ACE-I in all 84
patients who had been on dialysis for at least one month at time of starting
ACE-I. There was a significant rise in K, the mean increasing from 5.0
mmol/liter to 5.4 mmollliter (P < 0.001). Seventy-four patients who had
never been on ACE-I acted as controls and over similar period, at similar
stage of dialysis, there was no significant increase in K. In the 69 HD
patients the rise in pre-dialysis K was significant, the mean increasing
from 5.1 mmol/liter to 5.5 mmol/liter (P < 0.001). This remained
significant even in anuric patients (urine volume ® 100 mI/day, P = 0.044)
and patients with residual urea clearance (KRU) 0.5 mI/mm. (P =
0.041). Inhibition of the extrarenal effect of aldosterone that has previ-
ously been demonstrated in anephric patients may be implicated. In the 15
CAPD patients there was no significant change in K. Loss of renal
function on ACE-I has been described. There was a greater drop in KRU
in ACE-I treated patients compared to control group (mean 5.6% vs. 2.5%
per month), but this did not reach statistical significance. Changes in K
were not correlated to changes in KRU. Such changes in K can be of
clinical importance particularly in patients with poor dietary compliance
and high pre-dialysis Kt
Bin-impedance identifies an elevated extracellular fluid volume in
hypoalbuminemic CAPD patients. C.H. Jones, S. W. Smye, C. G. Newstead,
E.J. Will, and AM. Davison, Departments of Renal Medicine and Medical
Physics, St James's University Hospital, Leeds, England, United Kingdom.
Hypoalbuminemia in CAPD is multifactorial and has been associated with
both excess cardiovascular disease and increased mortality. The relation-
ship between serum albumin and overhydration, as determined by multi-
frequency hioelectric impedance measurement of extracellular fluid vol-
ume, was investigated. Fifty-nine stable CAPD patients with no clinical
signs of fluid overload were assessed. Serum albumin, age, dialysate-to-
plasma creatinine ratio, normalized protein catabolic rate, daily urine and
peritoneal protein losses, and extracellular fluid volume (Vecf; using
impedance measurements between the right wrist and ankle made at 25
frequencies in the range of 5 to 50 kHz combined with a tissue impedance
model; Xitron Inc.) were measured in each patient. Veef was calculated as
a percentage of actual body wt (Vecf % ABW), of lean body mass derived
from anthropometry (Vecf % LBM) and of total body water (Veef %
Vtbw). Comparisons between those with a normal serum albumin ( 37
g/liter) and those with a low serum albumin (< 37 g/litcr) were made by
Mann Whitney U-test. Correlations with serum albumin were sought by
Pearson's test. We found that the D/P creatinine ratio, daily peritoneal
and urine protein losses, and extracellular fluid volume (Vecf % LBM and
Vecf % Vtbw) were significantly greater in patients with serum albumin <
37 glliter as compared to those  37 g/liter; I' < 0.05. Age and NPCR were
not different. Serum albumin was negatively correlated with Vecf % LBM,
r —0.25; P = 0.05, Veef % Vtbw, r = —0.39; P 0.002 and daily urinary
albumin loss, r =
—0.25, P = 0.06; hut not with any other variable. We
conclude that subclinical overhydration in part determines hypoalbumin-
emia in CAPD patients. Serum albumin is negatively correlated with Vecf
% Vtbw and this proportion is significantly increased in hypoalbuminemic
patients. Multifrequency bioelcctric impedance is able to identify these
abnormalities.
Residual renal function with proteinuria in CAPD patients interacts
with audit of serum albumin. D.N. Bennett-Jones and S. Jenner, Depart-
ment of Renal Medicine, Cumberland Infirmary, Carlisle, England, United
Kingdom. Low serum albumin is an important predictor of mortality in
dialysis patients and is believed to relate to underdialysis. Consequently
the Renal Association standards document (1995) specifies that "only a
small percentage of patients" should have an albumin concentration
outside the normal range. However, the effect of proteinuria on plasma
albumin in this context has received little attention. Audits of our CAPD
program between May 1991 and October 1996 showed that the proportion
of patients with plasma albumin less than 35 g/liter increased from 23% to
67%. There was no detectable reduction in adequacy of dialysis measured
by Kt/V and creatinine clearance, including residual renal function, during
the same period. In a retrospective analysis, plasma albumin was measured
within 14 days of a measurement of 24-hour urinary protein excretion on
228 occasions in 69 patients. Measurements were excluded if the patient
had commenced dialysis or had CAPD peritonitis in the previous 28 days,
or within three months of a previous result. This left 133 measurements of
plasma albumin and proteinuria in 64 patients. We found a significant
inverse correlation between protein excretion and plasma albumin for all
measurements (N = 228, r = —0.297, P << 0.001) and also after exclusions(N = 133, r = -0.302, P < 0.001). Multiple regression analysis suggested
that the level of proteinuria has more influence on plasma albumin than
does urine volume, urea excretion, Kt/V or creatinine clearance. Five of 13
(38%) patients with plasma albumin < 30 g/liter and proteinuria < 1 g/24
hours died within 12 months, compared with 1 of 8 (12.5%) patients with
albumin <30 g/liter and proteinuria > 1 g/24 hours. We conclude that the
practice of recommending CAPD primarily for patients with residual
urine output may impair plasma albumin audit results as a consequence of
proteinuria without necessarily adversely affecting patient survival.
Improved diagnosis of early acute rejection using a Bayesian Belief
Network. P.N. Furness, J.J. Kazi, and ML. Nicholson, Departments of
Pathology & Surgery, Leicester General Hospital, Gsvendolen Road, Leices-
ter, England, United Kingdom, and Sindh Institute of Urology & Transplan-
tation, Karachi, Pakistan. The detection of acute rejection can be extremely
difficult in the early stages of the process. A histological diagnosis is
considered to be the 'gold standard,' but the early changes develop
gradually, and can be seen in some stable grafts, so mild acute rejection
can often be missed or over-diagnosed. The development of the Banif
classification of renal transplant pathology has improved the reproducibil-
ity of assessment of transplant biopsies, but we recently demonstrated that
it has not improved the accuracy of diagnosis of early rejection. We
suggested that this is because Banff concentrates on tubulitis and intimal
arteritis, and ignores other potentially useful features. We therefore
developed a Bayesian Belief Network, a simple type of neural network, to
incorporate data on a variety of features in transplant biopsies in a
systematic way to produce a diagnosis in the form of a probability of acute
rejection. The system was 'primed' by grading each of 10 features in each
of 100 transplant biopsies where review showed that clear retrospective
diagnoses of rejection or not rejection could be made. The data produced
were used to calculate a conditional probability matrix, (CPM) which was
entered into the program 'Bayes for Win.' The network was tested on the
21 selected difficult biopsies that were used in the U.K. trial of the Banff
classification, as previously reported to the Association. When seen by the
transplant pathologists of the U.K., the average number of correct
diagnoses was 62%, and the maximum achieved by any one pathologist
was 18 of 21. Applying the network, the trainee pathologist whose
observations produced the CPM got 19 of 21 diagnoses right. A more
experienced pathologist also got 19 of 21 right, hut his observations were
shifted towards over-diagnosis of acute rejection due to interobserver
variation. The results demonstrate that consideration of features not
currently included in the Banff classification of renal transplant pathology
can improve the accuracy of diagnosis of early acute rejection. The
approach is applicable to other problems in clinical medicine and pathol-
ogy.
Detection of cytomegalovirus (CMV) infection by DNA hybridization
post-transplantation. IV.J.M. Fardon, G.S. Underhill, H. Yassa, S.A. Sadek,
and IC. Mason, Wessex Renal and Transplant Unit and Public Health
Laboratory, St Mary's Hospital, Portsmouth, England, United Kingdom.
Cytomegalovirus (CMV) remains a serious cause of morbidity and mor-
tality amongst renal allograft recipients. Current serological and culture
methods of detection are slow and insensitive. We investigated a novel
method of quantifying viral load in peripheral blood leukocytes using
DNA hybridization (Murex Hybrid Capture System) and compared it with
conventional viral culture techniques in predicting CMV disease. Forty-
eight patients were enrolled prospectively (3 withdrawn: I death, 2 graft
loss). Samples were taken every two weeks for 16 weeks (9 samples per
patient). We defined 3 groups of patients with decreasing clinical risks of
infection based upon the CMV IgG status of the donor and recipient at
the time of transplantation.
DNA hybridization Positive
Clinical CMV illness Yes No
Negative
Yes No
CMV pos to neg (N = 14) 2 4
CMV pos to pos (N = 19) 2 4
CMV neg to pos (N = 12) 0 5
0
1
0
8
12
7
Sensitivity = 80%, negative predictive value = 96%.
Viral cell culture Positive
Clinical CMV illness Yes No
Negative
Yes No
CMV pos to neg (N = 14) 1 1
CMV pos to pos (N = 19) 0 1
CMV neg to pos (N = 12) 0 3
1
3
0
11
15
9
DNA hybridization provides a rapid (same day) and reliable method of
detecting and excluding CMV disease. There is little doubt that this test
will have a major relevance in transplant monitoring.
Structural determinants of ultrafiltration coefficient in early diabetic
nephropathy. K Bahoolal, GA. Coles, and iD. Williams, Institute of
Nephrology, Royal Infirmary, Cardiff Wales, United Kingdom. Micropunc-
ture studies in diabetic rats have shown that values for glomerular
ultrafiltration coefficient (Kf) are similar to those found in nondiabetic
rats. The use of angiotensin converting enzyme inhibitors (ACEI) in
diabetes reduces glomerular capillary hypertension but maintains GFR by
an increase in Kf. Theoretical studies suggest that changes in basement
membrane permeability and/or glomerular epithelial cell structure are
important in the control of Kf. The aim of this study was to determine
whether changes in epithelial cell structure account for changes in Kf
found in diabetic nephropathy. Wistar rats were made diabetic by intra-
venous injection of streptozotocin. A further group of rats injected with
saline acted as non diabetic controls. Diabetic rats were divided into two
groups, one group received enalapril in their drinking water while the
other group acted as diabetic controls. Renal function and morphometric
studies were performed at four weeks. Results are expressed as mean
SD.
No DM DM
DM +
ACEI
GFR mI/mm 1.42 0.12 1.72 0.l5a 1.75 0.9
Capill surface >(/05/Lun2 2.01 0.28 2.93 0.l7 2.98 0.25k'
area (Spcw)
Basemt. memb nm 142 5 139 7 145 8
thick (BMT)
Epith foot width nm 453 11 506 13 519 ii
(W foot)
Epith slit width nm 43 2 34 3' 36 4"
(\V slit)
Values for BMT were similar between diabetic and nondiabetic rats.
Epithelial cell structure in diabetes demonstrated broadening of epithelial
foot processes (W foot) and a reduction in the width of the epithelial slit
available for filtration (W slit). In accord with previous studies ACEI
maintained GFR due to an increase in K,. However, Spew increases in W
foot and the reduction in W slit were not reversed by ACEI. These studies
suggest that changes in basement membrane permeability rather than
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epithelial cell structure account for changes in ultrafiltration coefficient
found in early diabetic nephropathy.
Regulation of receptor mediated endocytosis of albumin by P1 3-kinase
in opossum kidney (OK) cells. N. Bn,nskill, A. Tobin, S. Nahorski, and J.
Walls, Departments of Nephrology, and Cell Physiology and Pharmacology,
Leicester University School of Medicine, Leicester, England, United King-
dom. Receptor mediated endocytosis (RME) of excess protein may have
a toxic effect on proximal tubular cells. We were interested in the
regulation of RME of albumin by the enzyme phosphatidylinositol
3-kinase (P1 3-kinase) in opossum kidney (OK) cells. Experiments using
inhibitors wortmannin and LY294002 suggested that P1 3-kinase inhibition
may result in markedly reduced RME of ['251]-albumin. These inhibitors,
however, are not entirely specific for PT 3-kinase. To confirm regulation of
RME by P1 3-kinase, we expressed cDNAs for both bovine wild-type
(p85), and dominant negative mutant (p85) forms of the p85 regulatory
subunit of P1 3-kinase in OK cells. Since PT 3-kinase functions in
downstream signaling from growth factor receptors, unregulated expres-
sion of PT 3-kinase could profoundly effect cell growth. Therefore, we
inducibly expressed these enzyme subunits using the Lac Switch gene
expression system. With this system, expression of transfected genes
should be repressed until cells are treated with isopropyl p-D-thiogalac-
topyranoside (IPTG). The transfected cells were screened with anti-p85
antibodies. Transfected cells proliferated and grew normally. Under basal
conditions p85 and p85 transfects demonstrated no expression of the
transfected gene. However, on treatment of cells with 5 mi IPTG,
expression was briskly induced. Significant expression of transfected genes
was observed after two hours and reached a maximum after 18 hours.
Induction of expression of p85 by IPTG resulted in reduced RME of
['25T]-albumin. The degree of reduction closely paralleled the expression
level of p85. At maximal expression levels of zp85, RME of [125II
albumin was almost entirely abolished. Expression of p85 had no signifi-
cant effect on ['251]-albumin RME. Time course studies of ['251J-albumin
uptake in p8S cells indicate that P13-kinase regulates an early step in
RME. These results demonstrate the utility of inducible gene expression
systems in proximal tubular cells, and suggest that P1 3-kinase regulates an
early step in RME of albumin. The regulatory mechanisms of RME may
interact with growth related signaling pathways.
Alteration of type IV collagen and fibronectin turnover in proximal
tubular cells (PTC) in response to D-glucose. A. 0. Phillips, K. Morrissey, J.
Martin, L. Eynstone, iD. Williams, and R. Steadman, Institute of Nephrol-
ogy, Royal Infirmary, Cardiff Wales, United Kingdom. Thickening and
reduplication of the tubular basement membrane has been reported as an
early event in diabetic nephropathy. Changes in synthesis of proximal
tubular Type IV collagen have been reported to prelate any light
microscopic changes within the glomerulus. In the current study we have
examined the effects of elevated D-glucose concentrations on PTC type IV
collagen and fibronectin turnover. Incubation of confluent growth arrested
PTC with 25 msi D-glucose led to accumulation of both type IV collagen
and fibronectin (all experiments were performed under serum free
conditions). This effect was maximal at 48 hours and represented a
sevenfold increase over L-glucose controls for fibronectin (N = 4, P =
0.09) and a fivefold increase for type IV collagen (N = 3, P = 0.01).There
was, however, no increase in mRNA for either type IV (al) collagen or
fibronectin at any time point up to 48 hours following application of
D-glucose. Using tissue culture inserts to grow cells in polarized culture,
the polarity of type IV collagen and fibronectin production was studied.
Addition of 25 mti D-glucose to either apical or basolateral aspects of
growth arrested cells led to increase in both type TV collagen and
fibronectin concentration in supernatant samples taken from the basolat-
eral but not the apical compartment. To investigate whether the observed
accumulation of collagen IV and fibronectin reflected a change in the
balance between the secretion of degradative enzymes and their inhibitors,
the synthesis of gelatinase enzymes and the tissue inhibitors of metallo-
proteinases (TIMPS) was investigated. Gelatin-substrate gel zymography
showed increased activity of Gelatinase A, but not of Gelatinase B in
response to addition of 25 ms D-glucose to growth arrested ITPTC. Under
the same conditions induction of Gelatinase A mRNA was demonstrated
within six hours of the addition of 25 mvi D-glucose. Despite the observed
increase in the synthesis of gelatinase A, there was a small but significant
overall decrease in gelatinolytic activity in HPTC culture supernatants
following incubation in 25 mi D-glucose. TIMP I and TIMP 2 mRNA
Sensitivity = 20%, negative predictive value = 90%.
'P < 0.05DM vs. No DM; "P <0.05 DM + ACET vs. No DM.
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levels were induced within 12 hours of addition of 25 mM D-glucose to
PTC, but not when cells were exposed to 25 mvi L-glucose. Increased
protein levels of both TIMP I and 2 as assessed by ELISA paralleled the
increase in mRNA. The increase in both TIMP I and TIMP 2 mRNA and
protein seen in response to the addition of 25 mat D-glucose was
abrogated by the aldose reductase inhibitor sorbinil. In addition, the
increase in type IV collagen and fibronectin concentration seen following
the addition of 25 mai D-glucose was also inhibited by sorbinil. These data
demonstrate that exposure of HPTC to elevated D-glucose concentrations
stimulated the accumulation of type IV collagen and fibronectin. Further-
more, we have demonstrated that this accumulation is unrelated to
increased gene transcription but may involve alterations in the degradative
pathway of these basement membrane constituents, and that these effects
are mediated by the activation of the polyol pathway.
Peroxynitrite may mediate progression in diabetic nephropathy. R. C.
Thuraisingham, C.A. Nott, S.M Dodd, and MM. Yaqoob, Anthony Raine
Research Laboratories and Department of Morbid Anatomy, Royal Hospitals
Trust, London, England, United Kingdom. Proximal tubular cells produce
nitric oxide (NO) and superoxide (02). NO and °2 react to form
peroxynitrite (ONOO), a powerful oxidant. ONOO nitrosylates tyrosine
moieties on proteins causing tissue damage. Our hypothesis is that ONOO
plays a role in early diabetic tubular damage and hence disease progres-
sion. Renal biopsies from patients with diabetic nephropathy (DM), acute
allograft rejection, ATN and glomerulonephritis (GN) were obtained.
Normal kidney specimens were taken from nephrcctomy samples (N = 10
for each group). The tissues were examined for the presence of nitroso-
tyrosine using an immunoperoxidase technique with a polyclonal antibody.
The samples were then arbitrarily scored and the results analyzed
(ANOVA and Students t-test for unpaired data). The DM biopsies
showed increased staining for nitrosotyrosine in the proximal tubules (P =
0.0001) and in the thin limb of the loop of Henle (P = 0.0006) compared
to all other groups. There was also increased staining in the ascending and
distal tubules in GN as compared to DM and ATN (P = 0.01). The
presence of nitrosotyrosine was detected equally in the collecting ducts,
glomerulus and interstitium in all 5 groups (P = NS). These data provide
the first evidence for the presence of nitrosotyrosine in both normal and
diseased kidneys. The significance of the findings in GN is unclear.
However, the study clearly demonstrates increased production of per-
oxynitrite in the proximal tubules of patients with diabetic nephropathy,
which suggests that oxidant injury of the proximal tubules plays an
important part in the pathogenesis of diabetic nephropathy.
Role of complement in experimental anti-GBM disease. N.S. Sheerin, T.
Springall, MC. Carroll and S.H. Sacks, Department of Nephrology and
Transplantation, Guy's Hospital and UMDS, London, England, United
Kingdom; and Harvard Medical School Boston, Massachusetts, USA. The
binding of heterologous anti-GBM antibody leads to acute glomerular
injury and proteinuria within 24 hours (heterologous phase). Following
the initial injury host antibody production occurs against the heterologous
antibody that acts as an antigenic target "planted" in the GBM (autolo-
gnus phase). We have examined the role of complement in the develop-
ment of glomerular injury during the autologous phase by comparing mice
rendered C3 or C4 deficient by homologous recombination with wild-type
C57/B16 mice. Urinary albumin excretion in the first 24 hours after the
injection of 1.0 mg of rabbit anti-mouse GBM IgG was significantly
greater in the wild-type mice. The protective effect of C3 deficiency
persisted with significantly lower proteinuria at days 7 and 14. However,
the early protection afforded by C4 deficiency was lost by day 7 with C4
deficient mice showing similar proteinuria to the wild-types. C3 could be
detected within the glomeruli of C4 deficient mice at all stages of disease,
consistent with alternative pathway activation. In contrast, at a higher 2.0
mg dose, despite a continued protective effect in the deficient groups
during the heterologous phase, all three groups had developed similar
albuminuria by day 7, and at day 14 the albumin loss in the C3 and C4
deficient mice exceeded that in the wild-type mice. In addition, serum urea
levels were significantly higher in the complement deficient groups at this
stage. The role of complement during the autologous phase of anti-GBM
disease is complex and varies with the dose of nephritogenic antibody. At
the low dose the injury is dependent on the alternative pathway of
complement activation. However, the protection is overcome at higher
doses of antibody at which stage other, as yet undetermined, mechanisms
are invoked.
Mutations in the gene for complement factor H in a family and in an
individual with hemolytic uremic syndrome (HUS). P. Warwicker, J.A.
Goodship, and TH.J. Goodship, Departments of Medicine and Human
Genetics University of Newcastle upon Tyne, England, United Kingdom. We
have previously demonstrated a genetic linkage between the familial form
of hemolytic uremic syndrome (HUS) and an area on chromosome lq is
known to contain the regulators of complement activation (RCA) gene
cluster. Mutation analysis of the factor H gene has revealed 2 mutations in
patients with HUS. In one individual with "sporadic" HUS that subse-
quently relapsed in a renal allograft, we have found a mutation in exon 1
of the gene. It comprises a deletion causing a frameshift and consequent
premature termination codon leading to decreased (35%) plasma levels of
factor H. Complement profiles in this patient, taken during a period of
good health and in the absence of HUS, revealed evidence of alternative
pathway activation with decreased levels of C3 and factor B. In a large
family with autosomal dominant HUS we describe a mutation in exon 20.
This point mutation causes an arginine to glycine change, which is likely to
alter structure and hence function of the factor H protein. We believe that
these findings lend further support to our hypothesis that factor H has a
crucial role in the etiology of several forms of HUS.
PKD2: The phenotype defined. N. Hateboer, R. Torra, E. Estivill, N.
Bogdanova, F. Davies, L. Lazarou, Mv. Dijk, M. Breuning, A. Saggar-Malik,
S. Jeffeiy, iL. San Millan, I. Martinez, R. Walker, P. Holmans, and D.
Ravine, Institute of Medical Genetics, University Hosj,ital of Wales, Cardiff
Wales, United Kingdom. Polycystic kidney disease type 2 (PKD2) has been
consistently reported to have a milder clinical phenotype than PKD1. All
reports to date have been limited to small numbers of families. Here we
report the findings of a multicentcr survey that aimed to define more
precisely the clinical expression of PKD2. Clinical data from 277 PKD2
affected individuals within 30 Caucasian families were collected from 7
centers, and then compared against previously published data from 288
PKD1 affected individuals within 17 Caucasian families. Survival analysis
was used to compare age at event data in the two populations, while
differences in prevalence of complications between PKDI and PKD2
individuals were assessed by logistic regression analysis to correct for age
and sex. It was confirmed that PKD2 patients had a later onset of clinical
presentation (median age 61.0 vs. 35 years) and longer overall survival
than those with PKDI (median age 69.1 vs. 53.6), and that renal survival
in PKD2 was also longer than in PKDI (median age 74.0 vs. 60.3 years).
PKD2 patients were less likely to be hypertensive (odds ratio 0.28, 95% CI
0.16—0.48), less likely to have a history of renal infection (0.47,0.28—0.81),
less likely to suffer a subarachnoid hemorrhage (0.18, 0.07—0.47), and less
likely to develop a hernia (0.46, 0.22—0.98). Liver cysts occurred more
commonly in PKD2 (3.4, 1.36—8.51). No parent of origin effects were
observed in either PKD1 or PKD2. PKD2, compared with PKD1, has a
milder clinical course with longer survival and fewer clinically significant
complications.
A selective deficiency in the mucosal yS T cell repertoire of patients
with IgA nephropathy (IgAN). A. Allen, C. Olive, S. Harper, A. Wicks, M.
Falk, and i. Feehally, Departments of Nephrology and Gastroenterology,
Leicester General Hospital, Leicester, England, United Kingdom; Depart-
ment of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; and
Richard Bright Renal Unit, Southmead Hospital Bristol, England, United
Kingdom. Mesangial IgA in IgAN is polymeric (pIgA). Normally, the
majority of pIgA is mucosally derived, but we have previously shown that
pIgA production is reduced in the duodenal lamina propria in IgAN,
suggesting that an abnormality of mucosal immunity may underlie the
pathogenesis of IgAN. IgA production is T cell dependent. T cells bearing
the yb T cell receptor (yb T cells) appear to play an important role in
mucosal immune regulation. The variable (V) regions of y and b T cell
receptor (TCR) chains fall into families: 4 Vy families (Vyl-4) and 6 Vh
families (Vbl-6). This study analyzed the V region usage of yfi T cells in
duodcnal mucosa and blood from patients with IgAN and controls, using
semiquantitativc RT-PCR. mRNA was extracted from duodenal biopsies
and peripheral blood mononuclear cells from 11 patients with IgAN and
11 matched controls, and eDNA synthesized by reverse transcriptase.
Primers specific for each Vy and Vh family were used in PCR. The
amplified transcripts were detected by Southern blotting and oligonucle-
otide hybridization, analyzing the results by densitometty. To correct for
the total amount of yS TCR eDNA in the samples, PCR for the fi constant
region (Ch) was also carried out, and V region expression calculated as a
ratio of C expression for each sample. In normal duodenal mucosa, yh T
cells predominantly expressed Vy3 and V3, while in IgAN, Vy3 and VM
usage predominated. Despite being the most frequently used of the Vy
families, Vy3 expression was significantly lower in IgAN duodenum than
in controls (Vy3:Ch 33 13 vs. 77 21, P < 0.023). Duodenal usage of
Vh3 was also strikingly low in IgAN (1 1 vs. 61 39, P < 0.043). No
significant abnormality of yfi TCR V region usage by peripheral blood T
cells was found in IgAN. This study shows that Vy3 and Vfi3 are the
predominant y TCR V region families used by y T cells in normal
duodenal mucosa, but that expression of both these V region families is
reduced in IgAN, indicating a lack of the most common type of mucosal
yfi T cell. This apparent "hole" in the y6 T cell repertoire may be a
fundamental abnormality of mucosal immunology in IgAN.
Differential regulation of C-C and C-X-C chemokine synthesis in
cytokine-activated human peritoneal mesothelial cells by IFN-y. R. Rob-
son, J. Witowski, P. Loetcher, J.D. Williams, and N. Topley, Institute of
Nephrology, University of Wales College of Medicine, Royal Infirmary,
Cardifl Wales, United Kingdom; and Theodor Kocher Institute, University of
Bern, Bern, Switzerland. Leukocyte migration during bacterial peritonitis is
characterized by an early influx of neutrophils and a subsequent, pro-
longed mononuclear cell phase. Recent data suggest that the mesothelium
might play a direct role in mediating the selective recruitment of leukocyte
populations via secretion of both neutrophil (IL-8) and mononuclear
cell-specific chemoattractants (MCP-1 and RANTES) following induction
by macrophage-derived cytokines (IL-i and TNFcw). Little is known,
however, about how this switch in leukocyte populations is controlled. The
present study investigates the role of IFN-y in the modulation of cytokine
driven human peritoneal mesothelial cell (HPMC) chemokine production.
Growth-arrested HPMC were stimulated with IFN-y (1 to 100 U/ml),
IL-113 (100 pg/ml) and TNFa (1000 pglml) alone or in combination for 24
hours, prior to quantitation of IL-8, MCP-i and RANTES peptide levels
by ELISA. Stimulation of HPMC with IFN-y alone (100 U/mI) resulted in
increased MCP-1 (4.3 0.2 ng/ml, mean SCM) and RANTES (0.015
0.007 nglml) peptide production above control levels (1.2 0.2 ng/ml and
0.003 0.001 ng/ml, respectively; N = 5, P < 0.05). Combinations of
IFN-y with IL-13 or TNFa resulted in significant and dose dependent
synergistic upregulation of the C-C chemokines, compared to IL-1j3
(0.13 0.03 and 9.4 1.7 ng/ml) or TNFa (0.03 0.02 and 5.3 0.6
ng/ml, for RANTES and MCP-1, respectively). This synergistic effect was
most marked for RANTES production, which was increased maximally by
9.6- and 33-fold above the additive values (N = 5, P < 0.05). MCP-1
production following combined IFN-y and IL-i j3 or TNFa stimulation was
increased by 1.7- and 1.8-fold above the additive values, respectively (N =
5, P < 0.05). In marked contrast, treatment of HPMC with IFN-y resulted
in inhibition of both constitutive and cytokine driven IL-8 synthesis. Basal,
IL-1J3 and TNFa stimulated IL-8 production were decreased by 69%, 26%
and 25%, respectively, in the presence of 10 U/mI IFN-y (N = 6, P < 0.05
for all). To investigate the mechanism of this differential effect we
examined the induction and stability of IL-8, MCP-1 and RANTES
mRNA expression by RT-PCR. Stimulation of HPMC with IFN-y, IL-i j3
or TNFa resulted in a time dependent increase in MCP-1 and RANTES
mRNA, which was maximal with combined stimulation. IL-8 mRNA levels
were induced by IL-113 and TNFa alone, but were inhibited in the
presence of IFN-y. mRNA stability experiments revealed that while IFN-y
+ IL-i stabilized MCP-1 and RANTES mRNA, the half life of IL-8
mRNA was reduced under the same conditions. These observations
suggest that the elevation of IFN-y observed during bacterial peritonitis
might play a role in controlling the phenotype of infiltrating leukocyte
populations into the peritoneal cavity during inflammation.
Nitric oxide (NO) production by the human peritoneal membrane. R.
Fernando, Z. Varghese, J.F. Moorhead, and A. Davenport, Department of
Renal Medicine and Transplantation, The Royal Free Hospital, London,
England, United Kingdom. CAPD peritonitis is associated with a tempo-
rary increase in peritoneal permeability, with increased protein losses. To
determine whether peritoneal NO production plays a role in this increased
permeability we determined total nitrate and nitrite (N02+NO3), using a
standard colorimetric method (Greiss reagent) following conversion of
NO3 to NO2. Total NO2+N03 in unused sterile CAPD dialysate was 5
0.5 I.tM (mean SCM), compared to that from 12 healthy CAPD patients(7 M 5F, mean age 58 4 years). The daytime bag was 40 3 LM and the
overnight bag was 87 8 J.LM (P < 0.05). Seven other patients (5 M 2F,
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mean age 58 years) developed CAPD peritonitis, total N02+NO3 in-
creased from 6.6 0.4 j.tm/hr (previous uninfected bag) to 16.5 2, 1st
bag, 14.7 2, 2nd bag, and 14.6 3, 3rd bag, respectively (day 1 of
peritonitis), and then declined with successful treatment to 9 2 (day 2)
and 6.5 1 jsm/hr (day 3). To determine whether human peritoneal
mesothelial cells (HPMC) could be a potential source of this peritoneal
NO, HPMC from 4 different donors were grown to confluence and then
rested for 24 hours, total NO2+N03 from medium alone was 5.4 0.4
mol/liter (mean SD), and then with HPMC 11.1 2.6; sterile unused
CAPD dialysate 4.4 0.7 and then with HPMC 11.3 2.6; sterile spent
dialysate alone 12.3 2.3 and then with HPMC 16.8 3; all HPMC was
P < 0.05 versus control conditions. Under resting conditions N02+NO3
production by HPMC was 210 45 nmol/mg cell protein (mean SD),
218 52 with unused PD fluid, but increased with increasing concentra-
tions of spent PD effluent (1/10 dilution) 317 54 and (1/2 dilution) 541
145 nmol/mg protein. This suggests that NO can be produced locally
within the peritoneal cavity, and is increased by both exposure to CAPD
dialysate and during CAPD peritonitis. In addition, HPMC grown in vitro
have the ability to produce NO under resting conditions and when
stimulated with spent dialysate, suggesting that they may be an important
source of local NO production.
Response of mesothelial cells to injury. An in vitro model to study
wound healing during peritoneal dialysis. S. Yung and M Davies, Institute
of Nephrology, University of Wales College of Medicine, The Royal Infirmaiy,
Cardiff Wales, United Kingdom. The presence of dialysis fluid within the
peritoneal cavity of patients undergoing CAPD can lead to the denudation
of the mesothelium, an event that can affect the long-term efficiency of the
peritoneal membrane. It is known that mesothelial cells can regenerate
after mechanical or chemical injury, but the manner in which it responds
is poorly understood. We have, therefore, developed an in vitro model of
wound healing to follow the response of human peritoneal mesothelial
cells (HPMC) to mechanical injury. Confluent, growth arrested HPMC
were mechanically wounded in a reproducible manner by scraping with a
fine glass rod (diameter 0.58 0.13 mm, N = 10) and the recovery of the
injured monolayer (time to close gap) monitored with time-lapse cinemi-
crography and by immunofluorescence (IMF). Monolayers were cultured
in Medium 199 alone or in culture medium containing varying amounts of
FCS or human serum (HS). The HPMC recovered confluency in serum
free medium between 60 to 72 hours after injury. This rate of recovery was
increased with the inclusion of FCS (0.1 to 10%) in a dose dependent
manner. HS had a similar effect on the rate of migration of cells into the
wound. Staining of the cells with bromodeoxyuridine (detects cells in
S-phase) suggested that the recovery for cells cultured in either serum free
conditions or FCS was due to cell migration rather than proliferation. The
manner in which cells migrated from the wound edge was further
investigated by IMF using antisera to vinculin, phalloidin and a-actinin
(markers for focal adhesions) and fibronectin, laminin, periecan, and
collagen Types I, III, IV and V (components of the extracellular matrix).
IMF showed the presence of organized stress fibers and focal adhesions
within cells migrating into the wound. Furthermore, de nova synthesis of
the above components of the ECM were also shown to accompany cell
migration. Studies using an undiluted pooled sample of overnight spent
dialysate from five patients free from infection exhibited a recovery
pattern similar to that obtained with 5% FCS. This study therefore
provides a novel in vitro model with which to investigate wound healing
within the peritoneum and the potential effect of PD on this process
Kinetics and specificity of protein uptake by proximal tubular cells
using an optical biosensor. H. Thakkar, D.J. Newman, PA. Lowe, and C.P.
Price, Department of Clinical Biochemistry, St Bartholomew's and Ale Royal
London School of Medicine and Dentistry, London, and Affinity Sensors Ltd,
Cambridge, England, United Kingdom. The affinity and specificity of
protein reabsorption by proximal tubular cells has been investigated using
techniques for monitoring endocytosis, demonstrating a high capacity but
low affinity process. However, it is not known whether uptake is through
binding to one receptor with differing affinities, or if there are several
classes of receptor, each specific for different proteins or groups of
proteins, such as high or low molecular weight. We have developed a novel
technique for analyzing the kinetics of protein binding to tubular cells
using an optical biosensor system that continuously monitors the binding
of cells to proteins immobilized on the sensor surface. Thus, low affinity
interactions can be monitored at near physiological temperatures without
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the use of inhibitors of endocytosis. We have studied the binding of
cultured LLC-PK1 cells to albumin (HMWP) and RBP (LMWP) immo-
bilized onto the sensor. By adding increasing concentrations of protein,
the albumin, RBP, n1m, 2m, cystatin C, specific and inhibitahle binding
of the cells was demonstrated. Calculating binding constants is difficult
with cells due to the large number of receptors expressed on their surface.
An apparent KA can be calculated from the reciprocal of the protein
concentration causing 50% inhibition in binding rate. These were: albu-
min, 8.0 >< iO M1; RBP, 2.7 X io vi a1m, 2.0 X l0 M; 2m, 4.2 )<
to M; cystatin C, 2.0 >< i0 M1. There were no significant differences
between the results whether RBP or albumin were immobilized. All of the
proteins gave similar shaped inhibition profiles indicating one receptor
with differing affinities for each protein.
Identification of new HLA class I region genes. M. Goldsworthy, A.
Sampath, J.M. Wilkinson, and S.H. Powis, Departments of Nephrology and
Transplantation, UMDS, Guy Hospital, London, England, United King-
dom. In addition to containing genes encoding the major transplantation
antigens, the MHC contains many other genes involved in the immune
response and genes associated with susceptibility to a large number of
human disorders. The complete characterization of this 4Mb region is thus
of fundamental interest. We have developed strategies to identify new
genes in the 2Mb class I region, the least well studied part of the complex.
HLA class 1 region cosmids were isolated from a chromosome 6 library by
hybridization with unique class I region probes and overlapping YACS.
Positive clones were restriction fingerprinted and analyzed by a suite of
computer programs which identified overlapping clones and assembled
them into contigs. Using this method 627 cosmids were isolated, of which
252 have been assembled into 56 contigs. Four cosmids were then chosen
to investigate sample sequencing as a means of identifying new class I
region genes. Cosmids were sonnicated to produce fragments of 0.5 to I
kb, subeloned and sequenced using an automated sequencer. Sequences
were compared with nucleotide sequences deposited in the Genhank
databases using the BLASTN algorithm. A number of potential new class
I region genes were identified, including a CDNA with homology to the tre
oncogene, the trans-activating factor SCJ and a member of the interferon
inducible 1-8 gene family. These observations suggest that sample se-
quencing is an efficient method for identifying new MHC genes, and
extend previous observations that the class I region contains a variety of
genes other than those encoding HLA antigens.
Exclusion of key nephrogenesis genes as candidates for vesicoureteric
reflux. S.A. Feather, D.C. Blaydon, T.M. Barratt, J. Alfison, AS. Woolf and
SM. Malcolm, Molecular Genetics and Nephrourology Units, Institute of
Child Health, London, England, United Kingdom. Primary, non-syndromic
vesicoureteric refiux (VUR) occurs in approximately 1% of children. The
most likely mode of inheritance is dominant with variable penetrance and
expression. Dominant mutations of the PAX2 transcription factor gene
have recently been identified in kindreds with the rare syndrome of VUR,
renal hypoplasia and optic nerve colobomas. Also, genetically engineered
mice with null mutations of the keratinocyte growth factor (KGF) axis and
the glial-cell line derived neurotrophic factor (GDA/F) axis have renal
malformations. The genes encoding PAX2, the KGF receptor and the
GDNF receptor (RET) are expressed in the developing ureter and are
located on the long arm of chromosome 10 (lOq). We investigated a large
kindred with primary, nonsyndromic VUR ascertained at our institute; the
family had 13 siblings, six of whom had VUR demonstrated on mieturating
cystogram (MCUG), and another teenage sibling with renal defects on a
DMSA isotope renogram but no evidence of VUR on MCUG. We assume
that the VUR has regressed in this individual. None of these individuals
had optic nerve colobomas. Polymorphic chromosomal markers spaced at
10 centimorgan intervals along loq were used to look for linkage to this
region in affected individuals in this kindred. The results showed that 2 or
more recombinants occurred in affected individuals with the VUR phe-
notype. This analysis excludes these three genes, known to be important in
the development of the urinary tract, in the pathogenesis of primary,
non-syndromic VUR in this family. Furthermore, our data suggest that
VUR in humans is, like autosomal dominant polycystic kidney disease,
genetically heterogeneous.
Association of an interleukin-lfi (IL-1j3) gene polymorphism with
diabetic nephropathy (DN). A.P. Maxwell, B. Loughrey, D.G. Fogarty, IC.
Han'on, and D.A. Savage, Regional Nephrology Unit, Belfast City Hospital
and Division of Molecular Medicine, The Queen s University of Belfast,
Belfast, Ireland. Genetic factors predispose a subset of patients with
insulin-dependent diabetes melitus (IDDM) to developing DN. IL-I
promotes the elaboration of extracellular matrix by mesangial cells in vitro
and the IL-i gene is a candidate implicated in the pathogenesis of DN. In
a case-control study we assessed if an IL-1f3 DNA polymorphism, which
correlates with an IL-1[3 "high secretor phenotype," is associated with DN.
IDDM patients were matched for duration of diabetes (mean 27 years)
and control patients were not receiving antihypertensive treatment and
did not have microalbuminuria. Genomic DNA from 93 patients with DN
and 94 patients without DN (controls) were PCR amplified with IL-113
primers. PCR products were digested with the restriction enzyme TaqI.
Gel electrophoresis resolved the IL1B* I allele (single hand) from the
ILlB*2 allele (two bands), permitting genotype to be assigned.
IDDM with IDDM without
nephropathy nephropathy
N % N
B*1,B*1 7 7.5 2 2.1
B*1,B*2 43 46.2 28 29.8
B*2,B*2 43 46.2 64 68.1
B*1 allele 57 30.6 32 17.0 P 0.003
B*2 allele 129 69.4 156 83.0
The TLlB* I allele was found more frequently in patients with DN
compared to controls (Odds ratio = 2.15; 95% CI 1.28 to 3.63). Similarly,
the TLIB*1 allele had a higher carriage rate in DN patients compared to
controls: 53.8% versus 31.9%, P = 0.004 (Odds ratio 2.48; 95% CI 1.31 to
4.71). In conclusion, in patients with IDDM the interleukinIB* I allele is
associated with diabetic nephropathy.
Autoantigen-derived peptide binding of HLA molecules associated with
Goodpasture's disease. R.G. Phelps, V. Jones, AN. Turner, and A.J. Rees,
Department of Medicine and Therapeutics, University ofAherdeen, Scotland,
United Kingdom. Class II molecules are highly polymorphic and differ
substantially in the range of peptides they bind and present for T cell
recognition. This is thought to be why inheritance of particular class II
alleles determines susceptibility to experimental autoimmune diseases in
mice. Class II alleles are also associated with autoimmune diseases in
humans, and Goodpasture's disease provides an exceptional opportunity
to analyze the molecular mechanisms involved because it is caused by
autoimmunity to a defused antigen [the 230 aa NC1 domain of the a3
chain of type TV collagen (n3(IV)NC1)I and has strong positive (with
DRI5 and DR4) and dominant negative (with DR7 and DR1) HLA class
II associations. An inhibition binding assay was used to compare the
affinity of purified class II molecules for short synthetic peptides spanning
the sequence of cs3(IV)NC1. No peptide was found to bind DRI5 with
much higher affinity (> 10-fold) than to DRI or 7. DR15 in general bound
peptides with low affinity (3/23 < 100 nM) compared to DRI and DR7 (12
and 10, respectively). The only peptide which bound DR15 better than
DRI or DR7 hound DR 15 with only intermediate affinity (66 nat). The
peptide binding characteristics of DR15 suggest that the molecule does
not predispose to Goodpasture's disease by presenting a particular
ec3(IV)NC1 -derived peptide uniquely well, nor do DRI and DR7 protect
by inability to present such a peptide. However, DRI or DR7 could
capture a3(IV)NC1-derived peptides, preventing the display bound to
DR15, suggesting a possible mechanism of dominant protection. The
predominant (biochemically detectable) a3(TV)NC1-derived peptides
presented bound to DRI5 by a3(IV)NC1-pulsed APC were recently
characterized. Comparison of elass II binding of the naturally presented
peptides suggests that neither would be presented bound to DR15 by APC
coexpressing DR15 with DRI or DR7.
Anti-myeloperoxidase (MPO) antibodies interfere with the inhibition of
MPO by cacruloplasmin. S. V. Gnjfin and CM. Lockwood, Department of
Medicine, Cambridge University, Addenhrooke's Hospital, Cambridge, En-
gland, United Kingdom. We have previously described the specific inhibi-
tion of myeloperoxidase (MPO) by caeruloplasinin (CP). Further work
has been carried out to elucidate the nature of the interaction between
MPO, CP and anti-MPO antibodies, and to assess the impact of the
development of anti-MPO antibodies on the potential of MPO to generate
reactive oxygen species and so cause tissue damage. Anti-MPO antibodies
were purified from plasma from patients with known vasculitis and high
anti-MPO titers, identified at screening by indirect immunofluorescence
and antigen specific ELISA, by passage over MPO then protein G
columns. Absence of contaminating proteins in the eluate was confirmed
by SDS-PAGE. The inhibition of CP binding to MPO by anti-MPO
antibodies was measured in an ELISA, and dose dependent inhibition of
up to 96 3.4% seen following incubation with a rabbit polyclonal and 8/9
human affinity purified antibodies, but not following incubation with a
mouse monoclonal, 1/9 human affinity-purified antibodies or pooled
human immunoglobulin. CP inhibits MPO activity in Vitro by c.70% as
measured by the oxidation of tetramethylbenzidine (TMB), and this
inhibition is reduced in a dose dependent manner of up to 100 4.5% in
the presence of 8/9 human affinity-purified anti-MPO antibodies, corre-
lating with the inhibition of MPO-CP binding in ELISA. The affinity of the
MPO-CP interaction has been measured using a biosensor (Pharmacia
BIAlite), giving an association rate constant (ka) of 1.79 X iO 5.5 ><
iO M1 s and dissociation rate constant (kd) of 3.00 )< iO—± 5.8 X
i0 s'. These values demonstrate a significantly lower affinity interac-
tion (P < 0.001) compared to that between MPO and both mouse
monoclonal and human affinity purified antibodies (ka 1.10 X i0 to
1.85 x 106 M s; kd 1.5 x iO to 9.2 x iO s'). Affinity ranking has
been confirmed by ammonium thiocyanate disruption ELISA, suggesting
that following the development of anti-MPO antibodies, MPO will bind
these in preference to CP. The escape of MPO from CP mediated
inhibition may then result in persistent generation of reactive oxygen
radicals and enhanced endothelial cytotoxicity.
Resident renal cell populations may be able to function as antigen
presenting cells to CD4+ T cells. L. Lightstone, A. Salama, A. Malik, and
Y Fullwood, Renal Unit, Royal Postgraduate Medical School, London,
England, United Kingdom. Activation of CD4+ T cells requires specific
engagement of T cell receptors by MHC class Il-peptide complexes
expressed on antigen presenting cells (APC), as well as co-stimulation by
molecules such as B7, LFA3 and IAM1. Only a narrow range of so-called
"professional" APC constitutively express class II molecules. However,
inflammatory cytokines can induce expression on many cell types. Peptide
loading of class II is influenced by other molecules particularly invariant
chain (Ii) and HLA-DM (DM). We have shown, using discriminating
panels of alloreactive human T cell clones, that the array of peptides
presented by DR molecules differs between cells which do and do not
co-express Ii and DM. We therefore hypothesized that if "non-profession-
al" APC discordantly up-regulate class II, Ii and DM in an inflammatory
milieu, then novel self-epitopes might be presented by DR molecules to
non-tolerized T cells, thus precipitating autoimmunity. To test this hy-
pothesis we have begun to study the ability of resident human renal cell
populations to function as APC. We have shown that cultures of both
primary mesangial cells and transformed renal fibroblasts do not consti-
tutively express DR, Ii or DM molecules as judged by cell surface and
intracytoplasmic serology, confocal microscopy and Western blotting of
whole cell lysates. Further, using RT-PCR no mRNA for these molecules
is detectable. However, upon induction with interferon gamma (IFNy),
both cell types up-regulate expression of all three relevant molecules.
Confocal microscopy revealed DR molecules to be expressed in vesicular
structures throughout the cytoplasm, whereas Ii and DM were more
limited in their distribution. Dual staining revealed co-localization of DR
and DM. To assess whether DR, Ii and DM are co-ordinately unregulated,
RNA was extracted from cultures at different time-points after induction
with IFNy and RT-PCR performed with primers for the three molecules
as well as for constitutively transcribed actin. The data suggest that the
up-regulation may not be co-ordinate. Both cell types express LFA3 at rest
and can up-regulate expression of ICAM1 with IFNy. However, B7 is not
expressed consititutively or following induction. We are now testing the
ability of these cells to stimulate the panels of alloreactive T cells to assess
their competence as APC and to determine the predominant site of
peptide loading of induced DR molecules.
Distal convoluted tubule: An unnecessary concept.A.J. liowie, C.J. Lote,
arsd P.M. Stewart, Departments of Pathology, Physiology and Medicine,
Umversiiy of Birmingham, Birmingham, England, United Kingdom. Ac-
counts of the anatomy of the distal renal tubule define the distal
convoluted tubule as that part between the thiek ascending limb of the
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loop of Henle and the connecting tubule, which is the beginning of the
collecting system. In contrast to the complexity of the anatomical distal
tubule, the physiological parts are simple, with an early segment that is
impermeable to water and unresponsive to aldosterone, and a late
segment that responds to aldosterone and has variable water permeability
controlled by vasopressin. The anatomical site corresponding to the
division between the two physiological parts has not previously been
identified. We used dual staining immunohistologieal methods to investi-
gate this problem. Antibodies to Tamm-Horsfall protein were used as
markers of the thick limb in human and rat kidneys. An antibody to the
water channel aquaporin 2 was used as a marker of cells responsive to
vasopressin in the kidneys of Brattleboro rats, which have no endogenous
vasopressin but respond to endogenous vasopressin. An antibody to
11-beta hydroxysteroid dehydrogenase type 2 was used as a marker of cells
responsive to aldosterone in human kidneys, because this enzyme confers
specificity on the mineralocorticoid receptor and colocalizes with it. There
was an abrupt end to staining for Tamm-Horsfall protein in the tubule and
staining for both aquaporin 2 and 11-beta hydroxysteroid dehydrogenase
type 2 began abruptly at this point. An interpretation of these findings is
that the thick limb, known to be impermeable to water and unresponsive
to aldosterone, runs directly into a part of the tubule that is responsive to
both vasopressin and aldosterone, that is, has the properties of the
collecting system. The end of the thick limb corresponds to the physio-
logical junction between the early and late parts of the distal tubule. There
is no need to postulate existence of a distal convoluted tubule that has
properties different from either the thick limb or the collecting system.
IL-6 release from osteoblastic like cells by vitamin D related sterols
depends on cellular differentiation. C. Mcintyre, N.J. Schroeder, J. Bunin,
and J. Cunningham, Departments of Nephrology and Clinical Biochemistry,
The Royal London Hospital, London, England, United Kingdom. We have
previously demonstrated differential effects of the vitamin D analogues
19-nor-la,25-dihydroxyvitamin D2 (19-nor), 22 oxacalcitriol (OCT) and
1,25 dihydrotachysterol2 (i,25DHT2) on IL-6 release from cultured MG
63 cells, which are a relatively poorly-differentiated human osteoblast-like
cell line. OCT and 1,25DHT2 increased IL-6 release at a peak concentra-
tion of 10_13 M whereas 19-nor had an effect only at the higher
concentrations of i0— and i0— M. IL-6 is predominantly resorptive in
both normal bone and in a number of disease states, and we have now
studied the effects of these sterols upon the SaOS-2 human osteoblast cell
line, which is a more mature line with PTH responsivity. SaOS-2 cells were
grown to confluence and maintained in media containing 10% charcoal
stripped fetal calf serum for 24 hours and then incubated for 24 hours in
media containing the sterols of interest PTH (10° to 10° M), PTH
alone (10- to iO' si), calcitriol or IL-1j3 as a positive control.
Supernatants were assayed for IL-6 using a specific ELISA. The response
to 19-nor was similar to that seen in MG63 cells (mean increase over
control levels of 387%, P = 0.0002) in that there was no effect with
calcitriol. Both OCT and 5DHT2 had a positive effect only at the very high
concentration of iO- (185% and 149%, respectively, P = 0.02). PTH had
no effect on IL-6 release either alone or in combination with these
compounds.
IL-i 19.nor OCT l,25DHT2N=40 N=40 N=40 N=40
100 j.M >1500%
10 M 387%h 185%' 149%hi0 M 7% 64% 42%
Not significant; P <0.05 vs IL-6 release from CS-FCS control
serum.
Thus, these sterols have different effects in the two cell lines so far studied,
with marked differences in both the amount of IL-fl produced and the
sterol concentrations that enhance the production/release of this osten-
tropic cytokine. This suggests that bone in general and the osteoblast pool
in particular is not a homogenous target tissue for these sterols. It remains
to be seen if such differences can be exploited therapeutically.
Mutations in PAX2 are not a common cause of vesicoureteric reflux. D.
Ozanne, P. Warwicker, T.J-J.J. Goodship, andJ.A. Goodship, Departments of
Medicine and Human Genetics, University of Newcastle upon Tyne, England,
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United Kingdom. Following a report of a mutation in the PAX2 gene in a
family with renal anomalies, vesicoureteric reflux (VUR) and optic nerve
colobomas, we sought mutations in 20 individuals from families with
VUR. Intronic primers for the 12 exons were designed from the gemonic
sequence and SSCP analysis undertaken. Band shifts were observed in
exon I and exon 8. Both of these were found to be common polymor-
phisms on analysis of a panel of normal control samples. The exon 8
polymorphism is a synonymous single base change from C to G at position
1500. No mutations were found in PAX2 in the 20 individuals studied. We
conclude that PAX2 mutations are not a common cause of vesicourteteric
reflux.
Association of the ACE gene deletion polymorphism and early onset of
ESRF in PKD1 ADPKD. K. Baboolal, D. Ravine, J. Daniels, GA. Co/es,
and J.D. Williams, Institute of Nephrology, Royal Infirmaty, Cardiff Wales,
United Kingdom. Autosomal dominant polycystic kidney disease
(ADPKD) accounts for 10% of the end-stage renal failure (ESRF)
worldwide. There is marked variability in the age of onset of ESRF. In
some patients ESRF occurs in adolescence while in others ESRF does not
occur at all. Some of the variability in the age of onset of ESRF is
accounted for by differences in the genotypes responsible for ADPKD. At
least three different genes (PKD1, PKD2 and PKD3) code for ADPKD.
PKDI genotypes have a more severe clinical expression than non-PKDI
genotypes, with an earlier onset of ESRF. We hypothesized that pheno-
typic variation in PKDI ADPKD may also result from an interaction of the
PKDI ADPKD gene with other modifying genes. One candidate gene that
might account for the variable age of onset of ESRF in PKDI ADPKD is
the insertion/deletion polymorphism of the ACE gene. One hundred and
eighty-nine patients from 46 families with PKDI ADPKD were identified
from renal registries in the UK and Australia. These patients were
genotyped for the insertion/deletion polymorphism of the ACE gene by
polymerase chain reaction and flanking oligonucleotide primer combina-
tions. In the 189 patients the frequencies of the DD, ID and II genotypes
were 34%, 44% and 22%, respectively. The distribution of the genotypes
was similar to that expected from Hardy Weinberg equilibrium. The three
groups were comparable with regards to age, sex and prevalence of
hypertension. Of the 189 patients 52 (28%) reached ESRF at an average
age of 48 1 year. In patients with ESRF there was an excess of patients
homozygous for the deletion allele [DD 48%; DD vs. ID/TI, x2 = 9.97
(ldf), P = 0.0021. Patients homozygous for the deletion allele (DD)
reached ESRF at a younger age than heterozygotes (ID) and patients
homozygous for the insertion allele (II). The cumulative renal survival
(95% confidence intervals) were: DD, 52 years (range 48—57); II, 59 years
(54—63); ID, 64 years (56, 72). These differences in renal survival were
statistically significant: DD versus ID/Il, x2 = 6.13 (ldf) P = 0.013. Ten of
the eleven patients who reached ESRF before the age of 40 were
homozygous for the deletion allele. The relative risk for ESRF below the
age 40 for DD genotype was 17. For all ages there was an overall increased
risk of 1.4 for ESRF with the DD genotype. This study suggests that
co-expression of the deletion polymorphism for the ACE gene and PKD1
gene identifies patients with ADPKD who are at increased risk of early
onset of ESRF.
Short-term primary culture of rat renal proximal tubule cells. M.E.C.
Dockrell, MI. Noor, .4.F. James, B.M. Hendiy, Department of Medicine,
Kings College School of l.ledicine and Dent ist,y, London, England, United
Kingdom. Cell culture is a powerful tool for examining hormonal and
biochemical responses of renal proximal tubule cells (PTCs). However,
many established cell lines show variation from the originator cell
phenotype. The aim of this work was to produce cells in short-term
primary culture which retain the properties of rat proximal tubule cells.
Tubule fragments were isolated by a method modified from Vinay et al
(Am J Physiol 241:F403—F4l 1, 1981) involving the enzymatic degradation
of cortical slices. The duration of incubation with collagenase was
optimized for the production of intact fragments of tubule. Proximal
tubule fragments were cultured on 35 mm dishes in Ham's F12 Nutrient
Mix and the effects of various culture conditions on growth, estimated as
percentage cover of culture dishes, were investigated. Growth was com-
pared in 3 defined serum-free media: (I) medium alone, (2) medium +
insulin-transferrin, selenite and hydrocortisone, and (3) 2 + EGF 10 ng
ml '. Growth at five days was 6.25%, 17% and 21%, respectively. A
comparison of cell growth was made on cells grown in the presence of 10%
FCS for the first 48 hours with cells grown in defined medium, on
non-coated, poly-L-lysine-eoated or collagen-coated culture dishes. Cul-
ture dish treatment did not markedly affect growth in the absence of FCS.
However, in the presence of FCS, growth on collagen-coated dishes was
markedly greater, 66 3% compared with 25 3% for non-coated dishes,
suggesting attachment to collagen being important in the proliferative
effect of FCS. Cultures were incubated with parathyroid hormone (PTH)
or arginine vasopressin (AVP) and the resultant cyclic AMP(cAMP)
production was measured by radioimmunoassay. PTH (10 M) but not
AVP (10 M) increased cAMP compared to basal (2.7 vs. 0.8 and 1.1 vs.
0.8, pmol mg1 protein, respectively). These results indicate that the cell
cultures retained the characteristics of PTCS.
Investigation of the role of histidine residues 270 and 280 in the
intracellular pH sensitivity of ROMKI. S. Bhandari, M. Hunter, Depart-
ment of Renal Physiology, University of Leeds, Leeds, England, United
Kingdom. Potassium homeostasis is achieved through secretion of K ions
across the apical membrane of the cortical collecting ducts, via low-
conductance inwardly rectifying potassium channels, which may be either
ROMK1 or RACTKI. Acid/base status affects K secretion. The intracel-
lular pH sensitivity of these channels may underlie this form of regulation.
pH sensitivity may result from easily protonatable residues (histidine).
Mutagenesis of 2 conserved intracellular histidine residues at positions
270 and 280 in ROMK1 was carried out to investigate with a view to
identifying the pH-sensing regions. Point mutations (His to Leu) of these
residues were constructed. Electrophysiological recordings were per-
formed 2 to 4 days after injection of 50 nI of cRNA into Xenopus laevis
oocytes, using two electrode voltage clamp (TEVC) and macropatches, In
the TEVC studies, the bath solution was (mM): 100 KCI, 1 CaCl2, 2 MgCI2,
10 Hepes; pH 7.4. Intracellular acidification was obtained by replacing
KCI with an equimolar concentration of KHCO3, titrated to pH 7.4 with
HCI, gassed with 40% CO2. In the macropateh studies, the bath solution
contained (mM): 100 KCI, I EGTA, 2 ATP and 10 Hepes, with a pH range
of 6.2 to 7.8, titrated with I M KOH/HCI. Barium-sensitive currents were
seen with control ROMK1 and H280; conductance 78.3 8.3 sS, (N = 6)
and 69.4 11.4 j.rS, (N 8), respectively. No expression greater than that
seen with water injected controls was observed in H270, (N = 8). Indirect
intracellular acidification produced an approximately 90% reversible
reduction in current amplitude within 60 seconds for both ROMKI (N =
6) and H280 (N = 8). In excised inside out macropatches, the pKa was 6.68
with a Hill coefficient (HC) of 2.8 (N = 6) for ROMK1. For H280 the pKa
was 6.76 with a HC of 1.2 (N = 4). Thus, the H280 mutant is still
pH-sensitive, but the steepness of the relationship between intracellular
pH and channels activity is reduced. H270 did not induce channels. A
recent report has identified a leueine residue that confers pH-sensitivity on
ROMK1, but the present study suggests that histidine residues may affect
the degree of pH sensitivity.
Spontaneous channel run down in excised patches of a renal potassium
channel, ROMKI. S. Bhandari, M. Hunter, Department of Renal Physiology,
University of Leeds, Leeds, England, United Kingdom. ROMKT, a low-
conductance inwardly-rectifying potassium channel in the apical mem-
brane of the cortical collecting duet, is sensitive to phosphorylation by
cAMP-dependent protein kinase. Channel regulation is usually complex,
involving several kinases and phosphatases. In this study we have exam-
ined the effects of promoting phosphorylation, by the addition of ATP,
and inhibiting phosphorylation, by removal of Mg2', in excised, inside-out
patches from ooeytes expressing ROMKI channels. Eleetrophysiological
recordings were performed 2 to 4 days after injection of 50 uI of cRNA
into Xenopus laevis oocytcs, using two electrode voltage clamp (TEVC)
and excised macropatches. In the macropatch studies, the bath solution
contained (mM): 100 KCI, 0 1 Icpes, 1 EGTA (to chelate Ca2), which was
used alone, or to which 2 Mg2 was added, either alone or in combination
with 2ATP. All solutions were titrated to pH 7.8. Using TEVC, injected
oocytes had a barium-sensitive conductance of 78.3 8.3 p.S (N 6).
Excision of macropatches into any of the above solutions resulted in
spontaneous, irreversible channel run down. In the absence of ATP and
Mg2, the patch conductance (1.48 0.02 nS to 0.64 0.18 nS) declined
to around 50% within 90 seconds. Use of solutions containing Mg2
and/or ATP failed to produce any significant change in the degree of
channel run down. However, further run down could he induced by
acidifying the bath (intracellular) solution to a pH of 6.6, causing
irreversible loss of channel activity. Addition of ATP and/or magnesium
failed to affect channel run down in ROMKI, suggesting that there is no
allosterie effect of ATP on the channel, and that the endogenous kinase
activity is inadequate to support phosphorylation. Whatever the mecha-
nism of spontaneous channel run down, it seems to involve a separate
pathway from that invoked by acidification.
An analysis of effective peritoneal surface area (EPSA), fluid removal
and survival in CAPD. S.]. Davies, L. Phillips, P.F. Naish, and G.I. Russell,
Renal Unit, North Staffordshire Hospital Trust, Stoke-on-Trent, England,
United Kingdom. There is increasing evidence that EPSA, as measured by
solute transport (D/Pr) is an independent predictor of survival in CAPD.
To investigate if this is mediated through an effect on fluid balance, we
have analyzed its relationship to the total 24-hour peritoneal ultrafiltration
(PD24UF) and total 24-hour net fluid removal (TOT24) in a cohort of 143
patients at six months, in whom survival data were available (median
follow up 27 months). There was a significant inverse relationship between
D/Pc, and PD24UF (r = —0.27, P = 0.002) such that the range in D/Pr
ratios (0.5 to 0.9) was associated with an 800 ml reduction in the PD24UF.
This relationship remained significant even when the 24-hour urine
volume was added. D/Pr correlated with albumin (ALB), r =
—0.4, P <
0.0001 and total 24-hour protein losses (TPL), r = 0.44, P < 0.0001, but
not with age, sex or height.
All patients Anuric patients
P P
Variable Surv Non-surv value Surv Non-surv value
N 109 34 17 10
Sex ratio 1.41 1.41 0.48 1.52 1.51 0.44
Age 50.1 61.4 0.0003 46.7 58.3 0.036
Height m 1.65 1.65 0.46 1.61 1.67 0.08
D/P, 0.66 0.71 0.017 0.66 0.71 0.09
Albumin glliter 37.2 35.1 0.018 37.1 35.8 0.22
TPL g/24 hr 7.9 8.9 0.07 7.21 7.74 0.3
PD24UF ml 1019 802 0.05 1405 771 0.003
T0T24 ml 1818 1290 0.0001 1417 778 0.003
Comparison of these variables taken at six months in survivors (SURV)
and non-survivors (NON-SURV) are summarized above. It is apparent
that the influence of EPSA on ultrafiltration is not fully compensated for
by use of hypertonic solutions, and this has a particular impact in the
anuric patient dying early on CAPD.
Human peritoneal mesothelial cell (HPMC) monolayer; An in vitro
electrophysiologic study. F.K Li and TM. Chan, Division of Nephrology,
University Department of Medicine, Queen Mary Hospital, Hong Kong.
Solute clearance is an important function of the peritoneum in CAPD
patients. It is well recognized that the mesothelium creates an important
barrier capable of regulating the transperitoneal transport of solutes. By
using the Ussing chamber setup, we studied the eletrophysiological
characteristics of 10 separate HPMC monolayers, prepared from different
patients. HPMC isolated from human omentum were grown on porous
supports. The integrity of the HPMC monolayers were confirmed by light
and electron microscopy. Confluent mesothelial monolayers were used for
electrophysiologic studies. Values of the basal transmesothelial potential,
short-circuit current and transmesothelial resistance were low: 0.30 0.05
mV (apical side negative, mean SEM, N = 10), 4.5 0.3 j.A/cm2 (N =
10) and 50.2 4.6 flcm2 (N 10), respectively. The support upon which
the monolayers were grown contributed a small and variable (- 10 flcm2)
amount to the transmesothelial resistance. These values of resistance were
calulated from the currents required to achieve small potential displace-
ment. However, from the values of transmcsothelial potential and short-
circuit current, a transmesothclial resistance of 70 Oem2 was predicted.
Both resistance measurements indicated that the monolayer formed a low
electrical resistance epithelium. In conclusioo, the peritoneal mesothelium
offers little resistance to the diffusion of solutes. Its modulatory effect on
the exchange of solutes during dialysis, however, require further investi-
gations. The setup illustrated is useful in the studies of the functional
properties of the mesothelium and appears to be effective in the charac-
terization of transmesothelial ions transport.
TGFj3:TNFa interaction modulates mesangial cell fibronectin produc-
tion. I.Z.A. Pawluczyk and K.P.G. Harris, Department of Nephrology,
Letcester General Hospital, Leicester, England, United Kingdom. TGFJ3,
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PDGF, TNFs and IL-I /3 are cytokines whose presence in the glomerulus
has been associated with glomcrulosclerosis. We have previously reported
to this Association that individually these cytokines are only able to induce
modest increases in fibronectin (Fn) levels, although in combination
fibronectin levels are synergistically unregulated to a degree comparable
with that previously seen with macrophage conditioned medium. The aim
of the present study therefore, was to determine the mechanism of action
underlying the interaction between two of these cytokines (TGFI3 and
TNFu) in the initiation of the scarring process. Northern blot analysis
demonstrated that individually these cytokines significantly increased Fn
mRNA expression (P < 0.005), although in combination Fn mRNA
expression was greatly enhanced to levels greater than the sum of the
individual cytokines (TGFI3 1.79 1.7-fold, TNFa 4.6 1.2-fold,
TGF/3:TNFa 15.0 4.8-fold increase over control). Since matrix accu-
mulation can also occur as result of a decrease in matrix degradation gene
expression of the matrix metalloproteinase rat transin (stromelysin) and
its inhibitor TIMP-1 were also examined. Northern blot analysis demon-
strated that unlike message for Fn, transin mRNA levels were antagonis-
tically reduced in the TGFj3:TNFa combination to 11.2 6.7% of the
predicted sum of the individual cytokines (P < 0.001 vs. additive value).
TIMP-l mRNA expression, on the other hand, in the TGF/3:TNFa
combination was equivalent to the additive value of the individual
cytokines (93.2 12.9% of additive value, P = NS).Taken together, these
data suggest that the TGF/3:TNFa-mediated accumulation of fibronectin
occurs as a result of the combined effects of synergistically increased Fn
mRNA expression compounded by an antagonistic decrease in the transin
gene expression and an additive increase in TIMP-1 gene expression.
These data illustrate how TGFI3 and TNFo may interact in vivo, following
a macrophage influx, to initiate glomerulosclerosis.
Is abnormal neutrophil function in ESRF associated with increased
CAPD peritonitis? I. Dasgupta, Ci. Porter, MiD. Cassidy, AG. Mo,gan,
and R.P. Burden, Renal Unit, Nottingham City Hospital NHS Trust,
Nottingham, England, United Kingdom. Patients with end-stage renal
failure (ESRF) have an increased susceptibility to infections for a variety
of reasons, one of which may be impaired polymorphonuclear neutrophil
(PMN) function. We have reported previously that PMN intracellular
bacterial killing (1K), in patients with chronic renal failure who were
prospective candidates for continuous ambulatory peritoneal dialysis(CAPD), was significantly reduced in some and normal in others. We
reviewed the subsequent progress of the two groups (reduced bacterial
killing patients = low 1K, and normal bacterial killing patients normal
1K) to see if there was any difference between them with respect to CAPD
peritonitis rates. There was no difference between the two groups with
regards to age, sex and the underlying cause of renal failure. The results
are shown in the table below.
Group
Low 1K 65.24 3.71 31 9703 1 episode per 10N = 12 patient months
Normal 1K 90.92 1.23 21 12900 1 episode per 21N = 19 patient months
P values <0.0001 >0.5
Although the difference in PMN intracellular killing between the two
groups was highly significant (P < 0.0001), the apparent differences in
CAPD peritonitis rates were not statistically different (P > 0.5) in this
relatively small number of patients.
Acute renal failure (ARF); Factors influencing nephrology referral and
outcome. !.H. Khan, G.R.D. Catto, N. Edward, AM. MacLead, Department
of Medicine and Therapeutics University of Aberdeen and Renal Unit
Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom. The lack of
improvement in survival in ARF in the past 20 years could partly be due
to the increasing number of older patients with comorbidity presenting
with the condition. A recent study showed that only 50% of patients with
advanced ARF (Cr > 500 j.rmol/hiter) are referred to a nephrologist. We
therefore aimed to establish the incidence, factors affecting nephrology
referral and outcome of ARF in an unselected (predominantly Caucasian)
population. Case-notes of all patients who had a serum creatinine (5Cr) >
300 jLmoh/liter over a 12 month period (July 1, 1989 to June 30, 1990) were
Intracellular Number of Follow-up
killing % infections days
Rates of
peritonitis
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examined. ARF was defined as a rise in Se., over 300 jimol/liter for the first
time which then returned to below that level or to normal, or, if the patient
died during the acute illness, the clinical features suggested acute deteri-
oration of previously normal renal function. Patients were classified into
low, medium and high risk groups according to presence of comorbidity
and age. Three hundred and eleven patients met the criteria for ARF of
whom 51 had advanced ARF (Sr >500). The annual incidence of ARF
was 612/million population and of advanced ARF 100 pmp. The age
related incidence of ARF ranged from 30 pmp in the young age group (0
to 19) to 4266 pmp in the older age group (> 80). Overall, 22% were
referred to a nephrologist (34% after excluding those with advanced
cancer and age > 80 years). Referral of patients decreased from 100% in
the age group 0 to 19 to 5% in those > 80 years. Referrals in the low,
medium and high risk groups were 75%, 30% and 14%, respectively.
Patient survival at two years was 80%, 42% and 19% for the low, medium
and high risk groups, respectively (86%, 44% and 32% for referred
patients). In conclusion, the referral of patients with ARF and their
outcome was significantly influenced by age and presence of comorbidity
at presentation.
Adverse effects of late referral for nephrological opinion. P.4. Ruther-
ford, S. Rutherford, and P.J. T Drew, University of Wales College of Medicine,
Wrexham Maelor Hospital, Clwyd, Wales, United Kingdom. Current health
policies recommend an increasing role for primary care physicians in the
management of chronic disease. But delayed referral for nephrological
opinion may have adverse effects on prognosis. To plan dialysis services in
the future it is important to establish referral policies to nephrologists and
to demonstrate the consequences of late referral for a specialist's opinion.
Thus, the referral policies of primary care physicians were assessed by
questionnaire and all the case notes of those patients accepted onto the
chronic dialysis (> 90 days) program since 1987 were reviewed. Patients
transferred to this unit for dialysis after nephrological follow-up elsewhere
were excluded. A total of 86% of primary care physicians would refer
patients when serum creatinine was less than 400 .rmol/liter, and most
(81%) believed there was no age limit for dialysis and that patients with
malignancy were not necessarily excluded. Patients accepted Onto the
chronic dialysis program were divided into "early" (referral > 3 months
before dialysis commenced) and "late" (< 3 months) referrals.
Early Late
Male/female 44/45 33/25
Age at first dialysis 60 (18—78) 65 (19—86)
Hh at referral g/dl
Creatinine at referral umol/l
11.0 (7.5—15.8)
335 (64—1027)'
8.2 (4.6—13.5)
786 (2S9_2iOO)t
Phosphate at referral mmol/liter 1.5 (1.9—2.5) 2.3 (0.52—5.2)
Albumin at referral g/liter 38 (17—46) 35 (17—42)
Number dead 15 27
Active transplant status 39 13
Values are median (range), P < 0.05, b P < 0.001 vs. Early
Late referral for nephrological opinion is common and associated with
adverse biochemical parameters, poor transplant prospects and increased
mortality. There are clear differences with primary care physician-re-
ported referral policies and the nephrologist's guidlines. These findings
need to be addressed to allow earlier referral and improvements in patient
outcome. Planning of future dialysis services must acknowledge that many
patients with chronic renal failure present with a need for immediate
dialysis.
Variability in the post-dialysis urea rebound. i.E. Tattersall, K Far-
rington, and RN. Greenwood, Lister Hospital, Stevenage, Herts, England,
United Kingdom. After dialysis, the blood urea concentration rebounds
upwards as equilibrium is restored. Unless the rebound is taken into
account in the monitoring and prescription of dialysis, Kt/V will be
underdelivered by up to 30%. Similarly, unless the post-dialysis urea
concentration is measured at least 30 minutes after dialysis, the Kt/V will
he overestimated by up to 30%. Previous work has shown that the
post-rebound concentrations can be predicted from samples taken before
and immediately after dialysis. In this way the errors caused by the
rebound can be avoided. However, this predictability has not been tested
in unselected dialysis patients. It is expected that patients with heart
failure would have greater rebounds. We measured the blood urea
immediately before (pre), immediately after (post) and 45 minutes after
(reb) 95 routine dialyses in 95 unselected dialysis patients (mean age 60
years, 17% diabetic, 26% with heart failure). We found that the average
patient clearance time (a measure of the rebound) was 40 minutes in these
patients, which is 10% higher than in the previous experimental dialyses.
The variability was also much higher in the unselected patients (SD 27 vs.
15 mm). The highest patient clearance time was 205 minutes in a patient
with edema. Despite this increased variability, the rebound could be
predicted to within a mean of 0. 6 mivi. KtIV calculated using the predicted
value of reb was within 10% of the actual value in 90% of cases. Rebound
may be predicted in an unselected population using the equation:
reb = pre>< (post/pre) iTil
where t is dialysis time. However, edematous patients should have direct
measurements of rebound since it may be much higher than predicted.
Cognitive impairment in patients with renal failure is associated with
multi-infarct pattern dementia. M. Harber, P. Lass, JR. Buscombe, and A.
Davenport, Royal Free Hospital, London, England, United Kingdom, and
Gdañsk Medical Academy, Gdañsk, Poland. Cognitive impairment occurs
in a higher proportion of patients with end-stage renal failure (ESRF)
than the general population, and there is a marked excess of cardiovas-
cular and cerebrovascular disease in patients with ESRF. To investigate
the possibility that cognitive impairment in these patients may be second-
ary to occult cerebrovascular disease, we performed SPECT scans on
seventeen patients (12 male, mean age 54, range 29 to 72; 9 hemodialysis,
5 low clearance, 2 transplant and one CAPD) using 550 mbq of Tc-99 m
HMPAO. Only two patients had documented history of a TIA/CVA, six
had diabetes, fifteen had a history of hypertension, ten were smokers or
ex-smokers, eight had peripheral vascular disease, nine hypercholesterol-
emia, ten ischemic heart diease and five had a history of atrial fibrillation,
mean urea 24.9 mmol, mean Mb 11.6 g/dl. Using multiple regions of
interest the mean counts/pixel in the frontal lobes and temporal lobes was
compared to the ipsilateral cerebellum. Any areas of asymmetric uptake >
10% were noted at the mid thalamic level. To look for cortical infarcts,
three-dimensional (3D) surface mapping was employed. The mean right
and left frontal/cerebellar ratio (0.83 0.09 and 0.84 0.08 SD,
respectively) was not significantly different from the right and left mean
temporal/cerebellar ratios (0.84 0.07 and 0.85 0.07, respectively.
Previous studies have demonstrated < 0.8 correlates with an Alzheimer's
pattern). Thirty-five discrete cortical perfusion defects were seen in fifteen
patients. The similar counts bilaterally in the frontal and temporal lobes
combined with multiple cortical defects and areas of asymmetry suggested
that the majority of these patients have a pattern consistent with a
multi-infarct pattern dementia. This pilot study implies that there is a large
excess of occult cerebrovascular disease in patients with a history of
chronic renal failure and SPECT-scanning may be a useful method of
assessing prevalence and progression.
Exercise rehabilitation improves functional capacity and exercise tol-
erance in non-anemic dialysis patients. P.F. Naish, T.H. Mercer, C.
Crawford, and N.P. Gleeson, Department of Nephrologj, North Staffordshire
Royal Infirmary and Division of Sport, Health and Exercise, Staffordshire
University, Stoke-on-Trent, England, United Kingdom. This study examined
the effects of 12 weeks of exercise rehabilitation on the walking capacity
and self-reported exercise tolerance of non-anemic dialysis patients.
Fourteen patients (11 men, 3 women) receiving maintenance dialysis were
recruited to the study and assigned to either exercise rehabilitation
(REHAB, N = 7; mean SD 63 14.5 years) or control (CON, N 7;
59 12.3 years) groups. Exercise tolerance (assessed by a self-report of
walking impairment; W1Q) and functional status, assessed via a previously
validated, timed, continuous walking/stair-climbing task (WALK) [com-
prising a 50 meter walk, stair climb of 22 steps (total elevation of 3.3
meters), stair descent, 50 meter walki were assessed pre- and post-
intervention. Exercise rehabilitation comprised 24 sessions (frequency of
2/week), each incorporating 15 minutes of accumulated cycle ergometer
exercise (exercise intensity corresponding to an undifferentiated Rating of
Perceived Exertion of 13 on the Borg scale), in combination with a
leg/abdominal muscular endurance circuit. Results revealed (repeated
measures ANOVA5) significant group (REHAB, CON) by time (Pre,
Post) interactions for: (a) the WALK task with the REHAB group alone
decreasing Total Walk Time of 149 37 s to 130 32 s (P < 0.01), and
Stair Climb of 20.3 6.5 s to 15.3 4.4 s (P < 0.01); and (h) WIQ with
the REHAB group alone reporting an increased ability to walk faster (P <
0.05) while experiencing reduced symptoms of breathlessness (P < 0.05)
and leg weakness (P < 0.05). These observed improvements in walking!
stair-climbing performance, self-reported walking speed, and self-reported
exercise tolerance indicate that low-volume exercise rehabilitation can
enhance the capacity of dialysis patients to engage in selected activities of
daily living.
Comparative audit of hemodialysis patients treated at different sites
within one center. G.L. War.vick, A. Roebuck, S. Page, M. Gerrish, M.
Robinson, A. Keogh, and C. Mistty, Departments of Nephrology, Leicester
General Hospital, and Peterborough and District General Hospital, Leicester,
England, United Kingdom. A comparative audit of all hemodialysis (HD)
patients in a large nephrology center was performed using some of the
measures and standards recommended by the Renal Association. The
purpose was to compare the outcome measures among four different
populations that is, the main unit (A, N = 117), home HD (B, N = 28),
satellite unit with on-site nephrologist (C, N = 29), and satellite unit
without on-site nephrologist (D, N = 29). The following data were
collected on all prevalent HD patients using last available value at a given
date in 1996: age, biochemistry (pre-dialysis bicarbonate, albumin, phos-
phate, calcium, iPTH), hemoglobin, pre-dialysis blood pressure, erythro-
poietin usage, and urea reduction ratio (URR). A series of cumulative
frequency curves will display the data for the 4 Sites. There was consider-
able variation between sites for any given parameter. The % with Hb> 10
g/dl varied from 52 to 79% compared to the recommended standard of
80%. Adequate BP control varied from 64 to 72% for diastolic and from
64 to 79% for systolic (set at < 160 mm Hg irrespective of age) with home
patients performing the worst. Phosphate control was poor with only 45 to
69% achieving values < 2.00 mmol/liter. The % with serum albumin below
normal range varied from 0 to 31%. Site D was worst in these two
categories and has been identified as having limited dietetic cover.
Adequate dialysis (that is, VRR > 60%) varied from 76 to 61% with again
home HD patients faring worst. In an attempt to give an overall rating,
sites were ranked from 1 to 4 for each category and the scores summed.
This gave a rank order of C > D > A > B. This was not altered by
excluding bicarbonate and systolic BP data. These data provide some
interesting comparisons but need careful interpretation. The populations
are not strictly comparable, with the home patients being younger and the
availability of bicarbonate dialysis varying from 100% in one satellite unit
to 0% in home patients. However, the analysis has identified strengths and
weaknesses at different sites allowing the targeting of efforts to improve
patient care.
Comparative audit of hemodialysis patients using Renal Association
standards. G.L. Warwiclç P. Altmann, R. Burden, M Cassidy, G. Cohen,
and C. Misity, Departments of Nephrology, Universities of Leicester, Oxford,
Nottingham, Derby and Peterborough, England, United Kingdom. A com-
parative audit of hemodialysis (HD) patients in 5 renal units was
performed using some of the outcome measures and standards recom-
mended by the Renal Association. The following data were collected on
all prevalent HD patients (including main unit, satellite and home
patients) using the last available value at audit date: nnumber of patients,
age, biochemistry (pre-dialysis potassium, bicarbonate, albumin, phos-
phate, calcium, iPTH), hemoglobin, pre-dialysis blood pressure, erythro-
poietin usage, Kt/V and/or urea reduction ratio (URR). Each unit was
asked to return data to a central co-ordinator. Cumulative frequency
distribution curves were drawn for each parameter except where normal
laboratory ranges varied widely (that is, albumin, bicarbonate). These
were expressed as % within the local normal range. The % achieving the
Renal Association standards was also expressed for each parameter. Data
were collceted on a total of 694 patients, although not all units returned
data on all parameters and some data were missing for some patients. The
range of unit populations was 29 to 265. A series of cumulative frequency
curves will display the data anonymously. No unit performed consistently
worse or better across all parameters. However, there was considerable
variation between units for an individual parameter. The % with Hb > 10
g/dl varied from 45 to 68% compared to the recommended standard of
80%. Partly, this reflected erythropoietin usage. Adequate BP control
varied from 65 to 79% for diastolic and from 64 to 78% for systolic (set
at < 160 mm Hg irrespective of age). Phosphate control was poor with
only 56 to 69% achieving values < 2.00 mmol/liter. The % with serum
albumin below normal range varied from 0 to 50%. The effectiveness of
such audit is demonstrated by data from one center where monitoring of
URR over a two year period has led to a steady increase in the % of
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patients achieving the target value of> 60%. A regular audit of this type
can improve the quality of patient care, but the work involved in data
collection is time consuming. Many units find it difficult to extract the
relevant data and the standards set are difficult to achieve.
A practical guide to a minimum standard of dialysis dose. E.J. Will and
C. Bartlett, St. James's University Hospital, Leeds, England, United Kingdom.
The minimum standard for thrice weekly hemodialysis dose is moving
towards a Kt/V of 1.2. It may be natural to try to increase values through
piecemeal increment of individual prescriptions, but this may not readily
succeed. In fact, it is not at all clear in advance just what clinical effort will
be required to change cohort values given the entropy of the system, nor
how quickly they will change. On reflection, the goal is actually a Kt/V
distribution above 1.2, which is sustained over time, but the future range
of values must be uncertain. There is no a priori reason to believe that
targeting' will narrow the distribution of values. Indeed, in our hands the
SD of Kt/V increases at higher values: 0.10 at a mean Kt/V of 0.90, and 0.23
at 1.4 (2 pool). However, it is possible to make some predictions from
available information. The monthly profile of Kt/V values in our patient
cohort (N-- = 200) varied only by 0.03 (mean) and 0.04 (SD) over
1996, that is, the values were highly stable. A projection then suggests that
a stable distribution with a mean at 1.4 would still lead to more than 10%
of values falling below 1.2 at any one time. Limited current experience is
consistent with this. The important practical implication is that tinkering
with the specifics of dialysis such as blood flow, treatment time and
recirculation will he less useful and economical than, say, shifting directly
to a larger dialyzer (that is, a strategic change in practice is predicated to
move the entire group, rather than a preoccupation with minutiae). The
ambitious, notional target of a cohort mean at or above 1.4, with the aim
to achieve this set somewhat higher, allows the early expectation of a
stable outturn distribution, which lies largely above 1.2. This result may be
counter-intuitive, hut indicates how to maximise effectiveness and effi-
ciency in the management of the individual as part of a (dialysis)
population.
Long-term complications of dialysis. S.A. C. Harris and E.A. Brown,
Renal Medicine, Charing Cross Hospital, London, England, United King-
dom. Of 526 patients starting dialysis before January 1986, 196 have
survived more than 10 years. The majority had a functioning transplant for
part of the time. Fifty patients had hemodialysis alone and their notes have
been reviewed to collect data related to incidence and predisposing factors
for complications of hemodialysis. Mean age at start of dialysis was 43
years and mean duration of hemodialysis 14.5 years (range 10 to 23), 4
survived more than 20 years. Renal failure was most commonly due to
polycystic kidney disease or glomerulonephritis. Fifty-two percent of
patients developed ischemic heart disease, 26% cerebrovascular disease,
38% peripheral vascular disease, 20% acquired aortic stenosis, 77%
complained of joint pains, 72% had a parathyroidectomy and 50%
developed carpal tunnel syndrome. A total of 235 episodes of infection
were recorded, 41% related to vascular access or acquired in hospital or
on immunosuppressioo. Only 3 infections occurred that could be de-
scribed as opportunistic. Twelve patients were hepatitis C positive.
Thirty-five of these patients have died, 20 from cardiovascular disease, 5
from infections. Three patients withdrew from dialysis. In comparison, 131
successfully transplanted patients, mean age 33 years at start, have been on
dialysis for an average of 17 years, (range 10 to 31) and 40 patients have
survived for more than 20 years. Fifteen of the hemodialysis group
(survival 11 to 23 years) and 90 of the transplanted group (survival 10 to
31 years) are still alive. In conclusion, long-term survival on renal
replacement therapy is dependent on successful transplantation. Compli-
cations, morbidity and mortality are high after 10 years of dialysis.
Epidemiology of pre-end-stage renal failure in a British district. N. St.J.
Drey, P. Roderick, M. Rogerson, and G. Weavind, Wessex Inst itutefor Health
Research and Developmen4 The University of Southampton, Renal Medicine,
Southampton General Hospital, and Chemical Patholo, Southanipton
General hospital, Southampton, England, United Kingdom. The epidemi-
ology of end-stage renal failure (ESRF) has been described in population
based studies in order to determine the need for renal replacement
therapy (RRT). However, the characteristics and scale of pre-end-stage
renal failure (Pre-ESRF) is less well understood. This study aimed to
determine the incidence of Pre-ESRF in a defined population and its
soeio-demographic determinants. Incidence rates derived from new cases
of diagnosed Pre-ESRF in Southampton Health Authority residents,
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1992-1994, as determined by a persistently raised serum creatinine (Se, 
150 iemol/liter) identified from chemical pathology records of South-
ampton General Hospital, those of hospitals in neighboring districts and
cross-referenced to RRT patients, the local nephrologists' clinical data-
base and death certificates. Validation of diagnosis by note searches of
medical records. There were 3859 cases of renal failure in the two years
1992 to 94, the total annual rate of renal failure of 4217 pmp. There were
1452 cases of CRF (38%), 1355 cases of ARF (35%), and 1052 unknown
cases (27%). The age distribution was as follows: CRF 88% were >60
years old, ARF 84% were > 60 years old, and Unknown 87% were > 60
years old. Further analysis after validation of the unknown diagnosis
category will present the age sex and ethnic patterns of CRF and ARF.
The implications for planning general nephrology services will be dis-
cussed.
Coping with demand—The provision of renal replacement therapy in
England and Wales. G. Ferris, P. Roderick, and T. Feest, Wessex Institute of
Health Research and Development, Southampton University and Renal Unit,
Southmead, Bristol, England, United Kingdom. The National Renal Review
described the level of service provision for renal replacement therapy in
England in 1993. It highlighted the need for continued expansion of
services to both cover unmet needs and to cope with their inevitable
growth of the stock of patients on RRT. The 'hub and spoke' model was
recommended as a feasible strategy for service development. As well as
increasing the quantity of services improvement in the quality of renal
services has been taken forward by the Renal Association's Standards
documents. A repeat survey has been undertaken of all renal units in
England and Wales to document service provision at the end of 1995. A
structured questionnaire was sent to all 57 units (52 in England). The
response rate has been 95% (N = 54). This paper will present information
aggregated at the national level and will describe inter unit and geograph-
ical variation on: (i) medical staffing levels; (ii) renal unit facilities such as
nephrology beds and stations; (iii) number of acceptances on RRT,
prevalent eases ("stock") broken down by modality; (iv) Satellite unit
provision such as number, size, siting, modalities provided and medical
care; (v) processes of dialysis bicarbonate in heniodialysis, disconnect
catheters in peritoneal dialysis, type of dialysis membranes, type of
monitoring of dialysis prescription. The changes in these variables will be
presented for the 45 English units who have provided comparable data in
both surveys in 1993 and 1995. The implications for the future develop-
ment of renal services will be discussed.
Retinal ischemia in hemolytic uremic syndrome (HUS): A predictor of
poor prognosis? R. Benzimra, A.J.O. Antao, K.L. Donovan, and A.J.
Williams, Department of Nephrology, Morriston Hospital, Swansea, Wales,
United Kingdom. HUS is characterized by thromboeytopenia, mieroangio-
pathic hemolytic anemia and renal failure. Ocular abnormalities including
vitreous hemorrhage, optic disc neovascularization and retinal detach-
ment have been reported in thrombotic thromboeytopaenic purpura, but
eye changes in HUS have thus far been limited to isolated eases. We
report clinical and investigative findings, treatment and outcome of all
eases of HUS seen in our unit between 1985 and 1997. There were 8
women, and blood pressure was similar in both groups; the mean age was
34 years (21 to 56). Five patients with severe retinal ischemia (multiple
cotton wool spots, occasional hemorrhages in the absence of papillo-
edema) had irreversible renal failure (ESRF). The other 5 patients had no
retinopathy and recovered their renal function.
Year Retinopathy Outcome
_________
Etiology
1985 Yes ESRF FH; OCP
1987 Yes ESRF OCP
1988 No Recovery Colitis
989 No Recovery Postpartum
1990 No Recovery F. coli 0157
1991 No Recovery Post-partum
1992 No Recovery Ca prostrate
1995 Yes ESRF —
1996 Yes ESRF OCP
1997 Yes ESRF OCP
Abbreviations are: FH, family history; OCP, oral contraceptive pill.
Fundoscopic appearances of retinal ischemia in adults with 1-JUS is a
predictor of poor renal prognosis (Chi squared 10.0, P = 0.0016).
European randomized trials in ANCA-associated systemic vasculitis: A
progress report (Jan 97). DR.W. Jayne and G. Gaskin, for the European
Systemic Vasculitis Clinical Trials Study Group (ECSYSVASTRIAL). Divi-
sion of Renal Medicine, St George's Hospital Medical School, London and
Renal Unit, RPMS, London, England, United Kingdom. Four randomized
clinical trials (RCTS) were launched in 1995 aimed at optimizing the
treatment of patients with ANCA-associated systemic vasculitis (AASV)
in clinical subgroups defined by disease extent and severity. One hundred
centers in 15 European countries are contributing to a network for the
design and performance of the RCTs and for the dissemination of
treatment recommendations. The network is supported by three core
facilities: a central serum bank, central histology review and archiving, and
a trials database.
Table. Patient recruitment (28/01/97)
Trial name NORAM CYCAZAREM MEPEX Total
Subgroup Non-renal Generalized
creatinine
<500
Severe renal
creatinine
>500
No. entered 18 131 47 196
No. required 90 146 150 386
% of required 20 90 30
UK entered 2 32 27 61
% of entered 11 24 57 31
Thirty-two UK centers have expressed an interest in the project and 13
have entered patients. The fourth RCT 'WARCRY,' for patients with
refractory disease, has been suspended due to difficulty with recruitment.
Early deaths have occurred in CYCAZAREM (2, 2%) and MEPEX (5,
11%), and predictable adverse effects of the trial medications have been
reported. Three CYCAZAREM and 8 MEPEX entries have successfully
completed the studies. In order to increase recruitment to NORAM and
MEPEX, modifications to the entry criteria have been agreed. Completion
of CYCAZAREM entry will allow analysis of the entry data Set later this
year.
Can renal scarring be prevented by earlier diagnosis of urinary tract
infection in infancy? I van der Voort, K Ven'ier Jone and A. Edwards,
Departments of Child Health and General Practice, University of Wales
College of Medicine, Cardiff Wales, United Kingdom. Urinary tract infection
in infancy gives rise to nonspecific illness and renal Scarring. The diagnosis
is easily overlooked because urinary tract symptoms are rarely present.
Although renal scarring has been linked with vesico-ureteric refiux, delays
in treatment and recurrent infection, attempts to prevent progressive
scarring by prophylactic antibiotics and surgical correction of vesico-
ureteric reflux have failed to reduce the prevalence of renal scarring as a
cause of hypertension or renal failure in childhood. This may be because
there was a delay in diagnosis and treatment of the first infection. This
study aimed to test the hypothesis that urinary tract infections in infants
and young children are overlooked in primary care, and that this may
account for failure to prevent renal scarring with good medical or surgical
management after referral to hospital. The general practitioner records of
children with renal scarring were examined for evidence of nonspecific and
febrile illnesses prior to the diagnosis of scarring. Cases were compared
with controls matched for age, sex and social class. We found that the
cases (N = 6) median consultation rate for infection or febrile illnesses
was 14 versus the control's (N = 23) median consultation rate of 7 (P =
0.004, Mann-Whitney test). This study demonstrates a higher rate of
presentation to general practitioners among children with renal scarring
compared with controls, and supports the hypothesis that failure to
diagnose urinary tract infection promptly in early childhood is a significant
and avoidable cause of renal scarring.
Characteristics of idiopathic membranous nephropathy in older pa-
tients. C.A. O'Callaghan, J. Hicks, S.H. Sacks, and J.S. Cameron, Renal
Unit, Guyc Hospital, London, England, United Kingdom. Although a
substantial proportion of patients with idiopathic membranous nephrop-
athy are elderly, no reports have characterized the disease in unselected
elderly patients. We have studied 128 unselected patients of all ages
presenting over a 20 year period and characterized the disease in the 44
patients older than 60 at presentation, the largest group to be reported to
date. The mean systolic blood pressures in the elderly was 211 mm Hg
compared to 147 mm Hg in younger patients (P < 0.05) and the mean
51CR-EDTA clearance was 57.9 compared to 85.1 in younger patients
(P < 0.0001). However, histological grading was similar in both groups as
was the degree of proteinuria and hematuria, suggesting that the glomer-
ular lesions were of similar severity. This suggests that clinical differences
reflect the effect of the same disease on elderly kidneys with less reserve
in patients with an elderly vasculature and an enhanced susceptibility to
hypertension. The Kaplan-Meier survival analysis demonstrates a worse
prognosis in the elderly, which is improved by treatment in selected
patients, especially with prednisolone and cyclophosphamide. At the last
point of follow up, 52.3% of elderly patients were still nephrotic, 40.4%
had ongoing renal deterioration and 34.1% had stable impaired renal
function. Thrombotic complications and rheumatological complaints are
relatively common in elderly patients. Our characterization of the disease
process in elderly patients over a prolonged period of follow up should
help clinicians decide on the likely outcome of the disease and the possible
benefits from therapy in elderly patients.
Oral-facial-digital syndrome type I is another dominant polycystic
kidney disease. S.A. Feather, P.J.D. Winyard, S. Dodd, and AS. Woolf
Molecular Genetics and Developmental Biology Units, Institute of Child
Health and Morbid Anatomy Department, The Royal London Hospital,
London, England, United Kingdom. The oral-facial-digital syndrome type 1(OFDI) is a rare disorder comprising malformations of the face, oral
cavity, hands and feet. Polycystic kidney disease (PKD) is a recently
recognized feature of this syndrome. We report the clinical, radiological
and histopatholugical features of an OFD1 and PKD kindred with 5
affected members in 3 generations. All patients were female and had PKD
asassessed by ultrasound scans. Furthermore, there was a strong family
history of miscarriage. Plasma creatininc was normal in 3, but 2 individuals
had end-stage renal failure in the second and fifth decades. Histochemical
analysis of renal tissue from one of this kindred showed predominantly
glomerulocystic kidney disease with a minor population of cysts from
distal tubules asassessed by staining with Arachis hypogaea lectin. Cyst
epithelia had a high level of mitosis as shown by staining with antisera to
proliferating cell nuclear antigen, and distal cysts overexpressed PAX2
protein, a potentially oneogenic transcription factor. This is the first report
of histology in a familial case of OFDI. We detected multiple pancreatic
cysts in one member affected by OFDI, although there were no symptoms
of pancreatic disease; this constitutes a novel radiological feature of this
syndrome. Although the renal disease superficially resembles autosomal
dominant PKD with macroscopic cysts and a dominant inheritance
pattern, histology shows a predominance of glomerular cysts and the
syndrome is X linked with affected males dying before birth. The extent of
disease was variable within the kindred and, in addition, markedly
asymmetrical features occurred in one individual. Both observations may
be explained by somatic mosaicism. The recognition of the accompanying
dysmorphic features is the key to a diagnosis of OFDI in a female child or
adult who presents with PK.D.
Chronic renal allograft rejection: Role of systemic hypertension. I.
Dasgupta, C.J. Porter, M.J.D. Cassidy, AG. Mo,,'an, and R.P. Burden, Renal
Unit, Nottingham City Hospital NTIS Trust, Nottingham, England, United
Kingdom. Despite advances in one year survival of renal allografts with use
of eyelosporine, no comparable improvement has occurred in long-term
graft survival. Non-immunological causes have been implicated, of which
systemic hypertension is an important factor. We reviewed adult renal
transplants retrospectively between 1986 and 1996 to see if there was any
association between blood pressure control and chronic graft dysfunction.
There were 485 renal transplants in this period all of whom received
cyclosporine. We studied 30 patients who developed progressive renal
dysfunction leading to loss of the graft more than one year after
transplantation and whose renal biopsies showed chronic rejection. They
were compared with 30 patients with functioning grafts matched for age,
sex, race and serum creatinine levels at six months (mean 178.2 64.2 vs.
173.03 59.5 jimol/liter). Mean serum cyclosporine levels in the two
groups were 251.9 110.1 ng/ml and 259.0 148.3 ng/ml, respectively.
The degree of blood pressure control in both groups was of an acceptable
standard ( 140/85 mm Hg). Furthermore, there was no significant
difference between the two groups in either pre- or post-transplantation
blood pressure as shown in the table.
Pre-transplantation Post-transplantation
BP mm Hg
Study group 140 17/81 7 146 9/87 5
Control group 145 9/83 5 144 9/86 5
There was, however, a significant difference between the two groups in the
number of early (within 90 days) biopsy-confirmed acute parenchymal
rejection episodes (27 in the study group vs. 12 in the control group, P
0.009). We conclude that renal allograft failure due to chronic allograft
rejection occurred in our study population in spite of good blood pressure
control.
Measurement of matrix protein mRNA levels in stable human renal
transplant biopsies. P.N. Fumess, G.R. Bicknell, L.L. Hall, L. Primrose,
J.A. Shaw, J.H. Pringle, and ML. Nicholson, Departments of Pathology and
Suigeiy, University of Leicester, and Leicester General Hospital and Leicester
Royal Infirma,y, Leicester, England, United Kingdom. The development of
improved strategies to prevent chronic allograft nephropathy depends not
only on improved understanding of the process, but also on improved
methods of measuring the rate of progression of damage to the transplant.
Graft survival can be predicted by histomorphometric assessment of
extracellular matrix at six months post-transplant. It is likely that this
deleterious accumulation is stimulated and controlled by cytokine synthe-
sis, especially TGF-pl. We therefore argued that measurement of the rate
of synthesis of extracellular matrix, as represented by tissue mRNA levels,
might provide a measure of the rate of graft damage earlier than six
months. Changes in matrix mRNA levels could represent a sensitive
measure of the efficacy of different treatments, and may shed light on the
nature of the underlying process. We measured levels of specific mRNA
species in single glomeruli plucked from the surface of protocol renal
transplant biopsies, using semicompetitive reverse transeriptase-polymer-
ase chain reaction (RT-PCR) with ELISA quantitation of the products.
Measurements of levels of glomerular GAPDH, a 'housekeeping' gene,
showed a large variation between different patients, though much less
between glomeruli from one patient. This is probably due to variation in
cellularity between glomeruli. With or without a correction for GAPDH
levels, we found considerable differences in the amount of mRNA for
TGF-1 and several matrix proteins. There is a close correlation between
levels of mRNA for TGF-131 and for several extracellular matrix proteins,
including collagen III, collagen IVa2 and tenascin. Surprisingly, elevated
TGF-131 correlates with elevated matrix metalloproteinase 2, but this may
be inactive, as there is simultaneously an elevation of mRNA for the
metalloproteinase inhibitors TIMPI and TIMP2. We do not yet have
sufficient follow-up data to assess correlations between these data and
graft survival.
Urinary nitrate as an early indicator of acute rejection following
cadaveric renal transplantation. A. Kumar, G. Halvorsen, P.H. Whiting, N.
Edward, N. Benjamin, S.H. Ralston, and G.R.D. Catto, Departments of
Nephrology, Medicine and Therapeutics, and Clinical Biochemistry, Aber-
deen Royal Infirmary and University of Aberdeen, Scotland, United Kingdom.
Nitric oxide production increases prior to clinical evidence of acute
transplant rejection in animal models. Since nitrate measurements provide
an accurate index of nitric oxide production in vivo, we studied the clinical
role of plasma and urinary nitrate levels in renal transplant patients.
Nitrate levels in plasma and urine were measured using the Griess
reaction after catalytic conversion of nitrate to nitrite. In total, 5 Out of 20
new renal allograft recipients suffered biopsy-proven acute cellular rejec-
tion episodes. Tn 3 of these cases, where rejection occurred within the first
week post-transplantation, an acute rise in plasma and urinary nitrate was
followed by a decline in plasma nitrate and urinary nitrate/urinary
creatinine ratio. In the remaining 2 eases of late acute rejection, a similar
pattern was observed over a week before there was clinical evidence of
rejection. Urinary nitrate levels using spot urine samples after an over-
night fast were as reliable as those in 24 hour collections. In patients with
histological evidence of chronic vascular rejection, significantly higher
plasma nitrate levels were noted than in healthy allografts and normal
adult controls, but the urinary nitrate/urinary creatinine ratio was un
changed. Patients with normal renal allograft function and intercurrent
active urinary tract infections demonstrated significantly increased pro-
duction of nitrite in the urine, hut plasma nitrate and urinary nitrate/
urinary ereatinine were not dissimilar from their matched controls with
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sterile urine. In conclusions, measurements of plasma and urinary nitrate
may facilitate early diagnosis of acute renal allograft rejection and help to
distinguish between chronic rejection and urinary infection.
OKT3 in renal allografts: Survival and complications. R.J. D'Souza,
J.TC. Kwan, R. Chang, and M.R. Bending, SW Thames Renal Unit, St
Helierc Hospital, Surrey, England, United Kingdom. Previous reports have
suggested that the use of OKT3 may increase the risk of life-threatening
infection and/or malignancy, particularly lymphoproliferative disorders
(LPD). We retrospectively examined the records of 40 patients (21 males,
19 females) who had received OKT3 for steroid-resistant rejection be-
tween 1987 and 1995, and compared the Outcomes of these patients with
age, sex, HLA-matched kidney allograft recipients controls. We used
cyclosporine and prednisolone as our primary immunosuppressive ther-
apy. Median follow-up was 34 (0 to 105) months in the OKT3 group and
52 (ito 91) months in the controls (P < 0.001). The OKT3 group had a
median of 2.7 (ito 6) rejection episodes compared with 0.4 (0 to 3) in the
controls (P < 0.001), and had significantly more methylprednisolone (4.1
g vs. 1.1 g, P < 0.001). Creatinine at both three months (232 178 vs.
170 89) and 12 months (219 119 vs. 141 46), was higher in the
OKT3 group (P < 0.01). At 12 months, 26 grafts were functioning in the
OKT3 group compared with 38 in the controls, P < 0.01. Significantly
more patients in the OKT3 group had severe life-threatening infections in
the first six months (11 vs. 2, P < 0.01). Patient survival up to 12 months
was no different between the two groups, although after 12 months
significantly more deaths occurred in the OKT3 group (12 vs. 2, P < 0.05).
These were mostly due to sepsis and cardiovascular-related causes.
Surprisingly, there was no reported case of LPD in the OKT3 group,
despite 14 patients also receiving ATG. Thus, OKT3 treatment may be
associated with an increase in severe infections, and reduced graft and
patient survival, although one has to take into consideration the adverse
circumstances of refractory rejection and higher total steroid dose.
Importantly, there was no increase in the occurrence of malignancy in the
OKT3 group.
Preliminary experience of Tacrolimus as the primary immunosuppres-
sive agent in renal transplantation. F.E. Harris, R. Chang, M. Sen, and
D.B.G. Oliveira, Department of Renal Medicine, St George's Hospital,
London, England, United Kingdom. Tacrolimus is a macrolide immuno-
suppressant with a mechanism of action similar to that of cyclosporine A.
Experience with Tacrolimus as a primary immunosuppressive agent in
renal transplantation is limited, but data from the United States suggest
that early rejection episodes are fewer, and long-term graft survival
greater, than with cyclosporine A. A prospective study of 26 consecutive
renal allograft recipients was commenced. Patients received a standard
immunosuppression protocol with Tacrolimus 0.1 mg/kg bid as the
primary immunosuppressant. Serum levels (trough) were maintained at 8
to 15 ng/ml for the duration of the study. Graft function, number of
biopsies performed, rejection episodes and any complications were re-
corded during the first three months of follow-up. Corresponding data
were obtained retrospectively for 36 patients who had received cyclospor-
me A as the primary immunosuppressant. After three months, 23 (88.5%)
patients in the Tacrolimus group were alive with a functioning graft,
median creatininc 96 mmol/liter. In the Tacrolimus group, 16 renal
biopsies performed in 10 (42%) patients showed 9 rejection episodes in 6
(25%) patients. In the cyclosporine A group, 47 biopsies in 22 (6 1%)
patients showed 17 rejection episodes in 12 (33%) patients. These
differences did not reach statistical significance. Adverse events included
glucose intolerance (12.5%), neurotoxicity (12.5%), gastrointestinal symp-
toms (58.3%), biopsy proven Tacrolimus nephrotoxicity (7.6%), and CMV
infection (7.6%). In conclusion, Tacrolimus is safe and easy to use. There
is a trend towards lower biopsy and early rejection rates, hut glucose
intolerance, neurotoxicity and gastrointestinal side effects are prominent
and need to he considered.
Homocysteine and cholesterol levels in cyclosporine- and azathioprine-
treated renal transplant patients. ME. Lafferty, J. Strachan, E. McGregor,
IS. Henderson, and MC. Jones, Renal Unit and Department of Biochemical
Medicine, Ninewells Hospital, Dundee, Scotland, United Kingdom. A recent
study of renal transplant patients has suggested that those treated with
cyclmporine in addition to azathioprine and prednisolone have higher
homocysteine levels irrespective of renal function. We measured plasma
homocysteine levels in our stable non-diabetic transplant patients (creati-
nine <200 prnol/liter) whose immunosuppression regime consisied of either
prednisolone and azathioprine (N = 11) or prednisolone and Neoral (N =
10). Fasting EDTA blood samples were separated within 20 minutes. Total
homocysteine (tHey) was measured by high performance liquid chroma-
tography. Ten patients had tHey levels elevated above normal (> 18
/.Lmol/liter), 5 from each treatment group. There was no significant
difference in the mean tHey in those receiving cyclosporine compared to
those treated with azathioprine (18.2 5.7 jzmol/liter vs. 19.9 3.8
rmol/liter). However, there was a positive correlation of tHey with serum
creatinine (r = 0.456) and a negative correlation between tHey and folate(r =
—0.415). In addition, mean total serum cholesterol was significantly
higher in the cyclosporine group compared to the azathioprine group
(6.7 0.86 mmol/liter vs. 5.2 0.42 mmol/liter, P < 0.01). Hyperhomo-
cysteinaemia in renal transplant patients is related to renal function and
not to medication. We are currently assessing the effect of folic acid
supplements on homocysteine levels in this group of patients.
Comparison of interstitial fluid and serum lipids and apolipoproteins
in patients with renal impairment. G.N.J. Wood, C.D. Short, MI. Mack-
ness, S. Arrol, D. Bhatnagar, and P.N. Durrington, Departments of Medicine
and Nephrology, Manchester Royal Infirmary, Manchester, England, United
Kingdom. Patients with chronic renal failure have increased cardiovascular
morbidity and mortality. The composition of interstitial fluid is likely to
have an influence on the development and progression of atherosclerosis.
We have therefore investigated the lipid and apolipoprotein concentra-
tions in interstitial fluid (IF) and serum creatinine (SCr) in 15 patients with
chronic renal failure: 5Cr creatinine 513 251 JLmol/liter (mean SD),
creatinine clearance 17.9 9.4 ml/min/i.73 m2. Interstitial fluid was
obtained by a suction blister technique. Compared to healthy controls,
serum total cholesterol was 5.48 1.23 versus 5.63 1.37 mmol/liter
(NS), triglyceride 1.61 (0.62 to 7.25) versus 1.43 (0.65 to 3.07) mmol/liter
(NS), HDL-c 1.27 0.35 versus 1.79 0.53 mmol/liter (P < 0.05), and
apolipoprotein B 97.5 30 versus 81.4 20.6 mgldl (NS).
Interstitial fluid Control CRF P
Total cholesterol mmol/liter 0.89 0.18 0.87 0.32 0.85
Free cholesterol mmol/liter 0.21 0.08 0.25 0.13 0.30
Triglyceride mmol/liter 0.17 (0.1—0.39) 0.32 (0.12—0.49) <0.01
Phospholipid mg/dl 0.47 0.12 0.45 0.14 0.75
Apolipoprotein B g/liter 0.18 0.07 0.77 0.39 <0.01
These results show higher interstitial fluid concentrations of trigliceride
and apolipoprotein B in patients with chronic renal failure, which may be
contributory factors to the increased vascular morbidity and mortality
observed.
Autoantibodies against oxidized low density lipoprotein in renal failure.
HE. Roxhorough, A.P. Maxwell, P. McNamee, and IS. Young, Department
of Clinical Biochemistry, Institute of Clinical Science, Queen's University of
Belfast, and Regional Nephrology Unit, Belfast City Hospital, Belfast, Ireland.
Cardiovascular disease is a major cause of morbidity and mortality in
patients with chronic renal failure. Elevated low-density lipoprotein
(LDL) is associated with atherosclerosis but it is the oxidized form of LDL
that appears to produce greatest atherogenie effects. Oxidation of I.DL
renders it immunogenic, resulting in the formation of autoantibodies.
Several studies have reported the presence of autoantibodies against
epitopes of oxidized LDL in human plasma and atherosclerotic lesions.
However, data on the relationship between autoantihody titers and
coronary atherosclerosis has not been consistent. The aim of this study was
therefore to develop an immunoassay that would allow quantification of
autoantihodies to oxidized LDL in renal failure, and so provide a possible
marker for atherosclerosis in these patients. Venous blood was collected
from 77 hemodialysis patients immediately prior to dialysis and from 59
healthy controls. Autoantihodies against malondialdehyde (NMA) modi-
fled LDL were measured using an enzyme-linked immunosorbcnt assay
and results expressed as a ratio of antibodies binding to MDA-LDL/
binding to native LDL. Mean autoantihody titers (± SD) of 1.28 0.13
and 1.25 0.15 (P = 0.37) were found in hemodialysis patients and
controls, respectively. No correlations were observed between antibody
titer and age, total cholesterol, LDL, HDL or triglycerides. As there was
no statistically significant difference found between patients and controls,
we conclude that the autoantibody titer does not provide support for the
presence of increased LDL oxidation in advanced renal failure. These
findings are consistent with several recent reports, which refute previous
results suggesting the existence of a relationship between antibody titres
and atherosclerosis.
Plasma homocysteine is elevated in renal transplant patients. J. V.
Woodside, D. G. Fogarty, CM. Loughrey, J. H". G. Yarnel4 A.P. Maxwell, and
IS. Young, School of Clinical Medicine, The Queen s University of Beifrist,
and The Regional Nephrology Unit, Belfhst City Hospital, Belfast, Ireland.
Increased plasma homocysteine is an independent risk factor for cardio-
vascular disease, including peripheral vascular disease, isehemic heart
disease and stroke. Homocysteine is increased in renal failure, but little
information is available about homocysteine and its influence on cardio-
vascular disease in renal transplant patients. We have therefore measured
plasma homocysteine in renal transplant recipients and control subjects.
Fasting EDTA blood was collected from 55 renal transplant recipients
with good renal function (creatinine clearance 61.3 2.8 mI/mm; urea
7.2 1.4 mmol/liter; creatinine 119 1.3 jsmol/liter; mean SD) and 32
age- and sex-matched control subjects with normal renal function. Total
homocystemne (tHey) was measured by high-performance liquid chroma-
tography with fluorimetric detection following derivatization with SBD-F.
tHey was increased in transplant recipients in comparison to control
subjects (10.9 1.5 jimol/liter vs. 6.7 1.3, P < 0.001). There was no
difference in tHey between patients receiving cyclosporine (N = 39, tHey
11.0 1.5 .rmol/liter) and patients receiving prednisolone + azathioprine
(N 16, tHey 10.8 1.6 p.mol/liter). Overall there was a significant
correlation between tHey and creatinine (r = 0.50, P < 0.001) and tHey
and urea (r = 0.41, P < 0.001), all variables being logarithmically
transformed. In a multivariate analysis, there was also a significant
independent correlation between tHey and the serum concentration of
cyclosporine (r = 0.42, P < 0.05), suggesting that cyclosporine may
influence homocysteine metabolism. Plasma homocysteine is increased in
renal transplant recipients even in the presence of minor degrees of renal
impairment, and this may contribute to increased cardiovascular disease
risk in these patients.
Lipid levels in patients with atherosclerotic renal artery stenosis. J.E.
Scoble, D. de Takats, M.E. Ostermann, JO. Connolly, iA. Beeso, KA.
Poyser, Ti. Peters, and R.A Sherwood, Departments of IVephrology and
Clinical Chemistiy, Kingc College Hospital and Guy's Hospital, London,
England, United Kingdom. Atherosclerotic renal artery stenosis (ARAS) is
an important cause of renal disease in the elderly. ARAS patients have
generalized atheromatous disease, but it is unclear whether there is any
specific lipid abnormality that predisposes them to renal artery disease.
We selected 32 patients with angiographically-proven ARAS and matched
these with control patients for age, plasma creatinine, sex and diabetes,
but did not exclude nonrenal atherosclerotic disease. Patients had fasting
lipid profiles performed by standard methodology. The clinical details of
the ARAS and control patients were (ARAS % vs. control %): hyperten-
sion, 67 versus 81 smoking 34 versus 53; ischemic heart disease 19 versus
28 cerebrovascular disease 9 versus 9 peripheral vascular disease 28 versus
6. The control patients had significant levels of atherosclerotic disease but
did not have proven renal artery disease. There was no significant
difference between the groups ARAS versus control in plasma cholesterol
(6.1 vs. 5.7 mmol/liter), triglycerides (2.32 vs. 1.68 mmol/liter), fibrinogen
(3.29 vs. 2.48 g/liter), Apolipoprotein B (1.24 vs. 1.31 glliter); HDL (1.00
vs. 1.16 mmol/liter), and LDL (4.06 vs. 3.72 mmol/iiter). There were
significant differences in lipoprotein (a) (0.31 vs. 0.58 g/liter) and apoli-
poprotein Al (0.95 vs. 2.09 glliter; P < 0.01). These results show that the
lipid profiles of ARAS patients do not show severe hypercholesterolemia
but are abnormal in apolipoprotein Al. The latter levels for the ARAS
patients were lower than described in coronary and carotid disease. ARAS
patients may need lipid lowering on the basis of nonrenal disease.
Manipulations in ARAS patients to alter the course of their renal artery
disease may need to target Apolipoprotcin Al rather than overall choles-
terol levels.
Renal length and function in atherosclerotic renal disease. A. Mikhail,
G. Cook, J. Reidy, J.E. Scoble, Departments of Nephrology, Nuclear Medicine
and Radiology, Guy Is Hospital, !,ondon, England, United Kingdom. Renal
size has been used as a surrogate marker for individual kidney function in
renal disease. We have sought to examine the relationship of bipolar
kidney length by ultrasonography and a new technique, single kidney
glomerular filtration rate (SKGFR), in atherosclerotic renal disease. The
SKGFR was determined by synchronous DMSA scan to determine
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divided and Cr-EDTA clearances to determine overall function. The
bipolar lengths were those from routine ultrasound examinations. Data
were obtained on 82 kidneys and related to their renal artery appearance
on angiography. The normal kidneys were those without stenosis where
angiography showed disease in the contralateral renal artery. The corre-
lation coefficients, significance and numbers (N) were: normal 0.34, P <
0.267 (13); occlusion 0.52, P < 0.031 (17); stenosis 0.39, P < 0.0 15 (37);
post-angioplasty 0.50, P < 0.113 (11); post-stent 0.5, P < 0.135 (3).
Although statistical significance was reached in the occlusion and stcnosis
groups, the correlation was poor with considerable scatter in all groups.
Other methods to assess renal volume may correlate better with function
but these are not widely available. We suggest that in assessing kidneys in
atherosclerotic renal disease for intervention or follow-up renal length
cannot be used, and that the measurement of choice is the SKGFR.
The electrocardiograph and outcome following renal transplantation.
D. Kavanagh, S. Morris, D. Northridge, S. Rodger, andA. Jardine, Renal Unit
and Department of Medicine & Therapeutics, Western Infirma,y, Glasgow,
and Department of Cardiology, Western General Hospital, Edinburgh, Scot-
land, United Kingdom. Cardiovascular disease is the major cause of death
following renal transplantation. Although patients on renal replacement
therapy (RRT) have many risk factors for cardiovascular disease including
hypertension, dyslipidemia and cigarette smoking, the relationship be-
tween these risk factors and outcome is less clear than in the general
population, and other factors such as echocardiographic measurement of
left ventricular mass may be more important. Since echocardiography is
not routinely performed, we have examined the relationship between
electrocardiographic (ECG) measurement of left ventricular hypertrophy
(LVH) and outcome following renal transplantation. A case-control
design was used. The case notes of 92 patients transplanted in the
cyclosporine era (since 1984) and who have since died (D) were compared
with 92 controls of the same sex, age within five years and transplanted in
the same year (A). The case records at the time of transplant were
examined for cardiovascular risk factors and the ECG copied and coded.
The ECGs were blindly assessed by three of the investigators. Age at
transplantation was not different [mean 46.7 (A) vs. 48.2 (D) years].
Treated hypertension was common [81% (D) vs. 77% (A)]. There was
ECO evidence of LVH in 52% of the dead patients compared with 33%
of the controls; LVH and strain was also over-represented [44%(D) vs.
19% (A)]). Isolated ischemic changes were identified in 29% (D) versus
19% (A) and previous myocardial infarction in 10% (D) versus 6% (A). In
a limited survival analysis, any ECG abnormality was associated with an
adverse outcome. The data show that ECG abnormalities are common
prior to transplantation and the incidence of LVH with and without
repolarization abnormalities is many times that seen in essential hyper-
tension. Further studies are required to determine whether these ECG
changes are reversible prior to and following transplantation.
Long-term bone loss in renal transplant recipients on cyclosporine
(CsA) monotherapy. S.J.K Shaikh, A.J. Hutchison, J.E. Adams, and R.
Gokal, Department of Renal Medicine, Manchester Royal Infirmary, Depart-
ment of Diagnostic Radiology, University of Manchester, Manchester, En-
gland, United Kingdom. The use of CsA has improved renal allograft
survival but its effect on bone is still controversial. We evaluated bone
mineral density (BMD) in 45 RTR (16 on CsA monotherapy, 20 on
prednisolone plus azathioprine (A+P) and 9 on triple therapy(A+P+CsA), with mean age 49 years (range 24 to 70) and mean
creatinine clearance of 72.6 21.2 mI/mm. Dual-energy x-ray ahsorpti-
ometry was used to record BMD at lumbar spine and right femoral neck,
while single energy x-ray absorptiometry measurements were taken at the
forearm (distal and ultradistal) at various time periods after transplanta-
tion (mean 125 months, range 38 to 294). Mean Z-seores at femoral neck
(—0.54, P < 0.03), lumbar spine (—0.08, P = NS), distal forearm (—0.46,
I' < 0.001) and ultradistal forearm (—0.99, P < 0.0001) were lower than
the mean of the healthy reference population. According to the WHO
definition, lumbar and femoral osteoporosis (t-score > —2.5 SD) was
present in 11% of the patients, while lumbar and femoral osteopenia
(t-score between —1 to —2.5 SD) in 30% and 50%, respectively. There was
no difference in the reduction of BMD at all sites between different
immunosuppresive groups. Different patterns of bone loss were observed
between males and females, with females experiencing greater loss at the
femoral neck than the spine. The reverse was true for men. There was a
trend of continued loss of axial and trahecular bone in post-transplant
period as far up to 25 years with gain at cortical and appendieular bone.
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Cumulative dose of prednisolone and serum 1,25-dihydroxyvitamin D3
correlated with lumbar and forearm BMD. Bone loss is common and
persists in long-term survivors of renal transplantation even in recipients
on CsA monotherapy.
Immuno- Lumbar Femoral Ultradistal Distal
suppression spine neck forearm forearm
Aza + Pred —0.33 1.33 —0.54 1.10 —0.26 0.98 —1.09 097h
(N = 20)
CsA 0.32 1.14 —0.53 0.96 —0.53 0.81 —0.70 0.77"
(N = 16)
Aza + Pred —0.24 1.30 —0.62 1.14 —0.81 1.11 —1.35 0.93
+ CsA
(N = 9)
Values are mean Z score SEM, P = NS between immunosuppressive
groups.
P < 0.00 1 vs. lumbar spine, h p < 0.05 vs. ultradistal forearm and
lumbar spine, respectively.
A rapid rise in bone density follows combined vitamin D therapy and
parathyroidectomy in renal failure. K.A. Hiliman, ..4.A. Brown, D.J.S.
Carmichael, and M.K Almond, Departments of Medicine and Surgeiy,
Southend Hospital, Essex, England, United Kingdom. Chronic renal failure
(CRF) with poor phosphate control and hypocalcaemia predisposes to
secondary hyperparathyroidism (HPT) and renal osteodystrophy. Addi-
tional bone diseases, osteomatacia, osteoporosis, aluminium toxicity and
low bone turnover contribute to the low bone mineral density (BMD)
found in patients with CRF. Earlier studies documented a rise in BMD
over several years following parathyroidectomy to correct HPT. The use of
pulsed vitamin D has been proposed as a method of medically controlling
the progression of HPT. Failure to control severe HPT continues to be a
problem resulting in parathyroidectomy. We studied 7 patients with
chronic renal failure (4 hemodialysis, 2 CAPD and 1 transplant) treated
with vitamin D who went on to parathyroidectomy. BMD at the lumbar
spine and left hip was measured in all patients using Dual Energy X-ray
Absorptiometry prior to parathyroidectomy, and biochemical markers of
bone disease were also recorded, such as intact parathyroid hormone
(PTH) alkaline phosphatase, phosphate and calcium. Serum calcium was
maintained post-surgery by calcium supplements and vitamin D. BMD
studies and biochemical data were repeated, one year post-parathyroid-
ectomy. Mean BMD at the lumbar spine was 84% of an age- and
sex-matched group at the time of surgery (range 63 to 112%). At one year
a significant rise had occurred (P < 0.05), mean BMD 90% (range 69 to
110%). Mean BMD at the left hip was 83% of an age- and sex-matched
group at the time of surgery (range 65 to 100%). At one year a significant
rise had occurred (P < 0.01), mean BMD 92% (range 77 to 102%). As
expected, a significant fall in PTH (P < 0.011 and calcium (P < 0.05) had
occurred. Alkaline phosphatase fell but this failed to reach significance
(P = 0.07); phosphate levels remained unchanged. In 4 patients total body
BMD and total body bone mineral content were measured showing mean
rises (87 to 89% and 2191 to 2284 g, respectively). We conclude that the
combination of vitamin D therapy and parathyroidectomy promotes a
significant and rapid rise in BMD patients with CRF. The long-term
consequences of this rise for future fracture risk and bone integrity
remains to be assessed.
Uremic serum and dialysis influences the constitutive release of IL-6,
serum IL.6R and IL.9 from osteoblastic.like cells. C. Mcintyre, N.J.
Schroeder, J. Burrin, and J. Cunningham, Departments of Nephroiogy and
Clinical Biochemistry, The Royal i.ondon Hospitals, London, England,
United Kingdom. Il.-6 and IL-9 have been identified as resorptive influ-
ences in a number of pathological states including osteoporosis, bone
disease associated with Grave's disease and renal osteodystrophy, and are
found in increased amounts in the serum of hemodialysis patients. To
examine the possibility that the uremic milieu (± dialysis) might alter the
release of these cytokines from hone, we studied its effect on two human
osteoblastic-like cell lines, MG63 and SaOS-2 (the latter a more pheno-
typically mature line with PTH responsivity). Pooled serum was collected
from ten male hemodialysis patients (dialyzing through flstulae) and ten
healthy male volunteers. Serum was sampled before and after a standard
hemodialysis session in an individual male patient. Aliquots of sera were
charcoal stripped overnight, using a standard protocol. SaOS-2 and MG63
cells were grown to confluence and maintained in nonstimulating media
for 24 hours, and then incubated for a further 24 hours in media
containing human serum at 10%. Supernatants were assayed using specific
ELISAs. In MG63 cells the presence of normal pooled serum was
associated with a fourfold increase in release of both IL-6 and IL-8, as
compared with uremic serum (peak IL-6 785 700.3 pg/mI, N = 36; peak
IL-8 38078 2435 pg/mI, N = 24; P < 0.0001). Conversely, serum IL-6R
levels were higher with the uremic serum (normal serum 5198 586
pg/mI, uremic serum 7592 559 pg/mI; P = 0.007). There was no
significant difference between the charcoal stripped sera. These results
were paralleled by those in SaOS-2 cells with all levels approximately 90%
lower. Post-dialysis serum caused an increase in the constitutive release of
IL-6 in both cell lines in comparison with predialysis serum but not to the
level of normal serum (results in MG63 cells summarized below).
Pre-HD Post-HD
Pooled
normal
Pooled
urcmic
IL-6 pg/mi 1014" 1621" 2490 1056
SEM 34.5 85 95 44.3
ap < 0.0001
These data show that in the presence of uremic serum, cultured osteo-
blasts produce less IL-8 and IL-6, but more serum IL-6R as compared with
normal serum. Post-dialysis serum partially restores this deficit, possibly
representing either removal by hemodialysis of an inhibitor of cytokine
production or the addition of a stimulator of the production of IL-6 and
IL-8 by cultured osteoblast-like cells, and this may have implications for
bone turnover in uremic patients.
bSpectrum of bone disease after renal transplantation: Correlation
between histomorphometry and densitometry. S.J.K Shaikh, A.J. Hutchi-
son, fE. Adams, A. Freemont, and R. Gokal, Departments of Renal
Medicine, Manchester Royal Infirmaiy, Diagnostic Radiology and Osteopa-
thology, University of Manchester, Manchester, England, United Kingdom.
The long-term effect of renal transplantation on bone is unknown. We
conducted a study on 45 renal transplant recipients (RTR), 16 of them on
cyclosporine monotherapy (C5A), 20 on prednlsolone plus azathloprine
(A+P) and 9 on triple therapy (CsA+A +P). Their mean age 49 years(range 24 to 70) and mean creatinine clearance 72.6 21.2 mI/mm. An
iliac bone biopsy was performed and bone mineral density (BMD)
measured at the lumbar spine, right femoral neck and forearm (distal and
ultradistal) using dual and single-energy x-ray absorptiometry
(DXA,SXA) at various intervals after transplantation (mean 125 months,
range 38 to 294). Histomorphometry showed normal bone (35%), os-
teopenia (18%), adynamic (18%), hyperparathyroid bone (22%) and
osteomalacia (7%). The rest had normal bone. However, 85% showed
abnormal osteoblast and/or osteoclast activities. There was a trend of
increased osteoclast activity in CsA monotherapy independent of PTH
activity. Mean BMD of RTR was lower than mean of healthy population
at all sites measured. By the WHO definition, lumbar and femoral
osteopenia was present in 30% and 50% of the patients while lumbar and
femoral osteoporosis in 11%. Reduced lumbar BMD were also noted in
adynamic lesion and hyperparathroid bone, while reduced forearm BMD
was noted in osteopenic and hyperparathyroid bone. There was no
difference in BMD between the immunosuppressive groups, but there was
a trend of continued bone loss at lumbar spine and bone gain at forearm
hone with increased duration of transplant for as long as 25 years. The
predictive value of DXA in osteopenia, adynamic and hyperparathyroid
bone at lumbar and femoral was poor (15%, 23%, 39% and 33%, 21%,
7%, respectively). Cumulative dose of prednisolone dose and serum
1,25-dihydroxyvitamio D correlated with lumbar BMD. Osteopenia is
common among long-term survivors of renal transplantation, even in
those on CsA monotherapy. CsA induces hone loss by suppressing
osteoblast and increasing osteoclast activities. DXA is useful in detecting
low bone mass, but it is of limited value in predicting the underlying bone
lesions.
